DIMITRIOS PKONTOYIANNISDIMITRIOS P KONTOYIANNIS8761KONTOYIANNIS, DIMITRIOS PProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson24592915Pemmaraju N, Shetty AV, Prieto VG, Jain N, Kontoyiannis DP, Borthakur GEuropean journal of haematologyDisseminated Saprochaete capitata (formerly known as Geotrichum capitatum and Blastoschizomyces capitatus) in a patient with acute myeloid leukemia. Eur J Haematol. 2014 Dec; 93(6):543-4.Eur J Haematol2014-03-24T00:00:002014Disseminated Saprochaete capitata (formerly known as Geotrichum capitatum and Blastoschizomyces capitatus) in a patient with acute myeloid leukemia.25086667Davoudi S, Anderlini P, Fuller GN, Kontoyiannis DPMycopathologiaA long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case. Mycopathologia. 2014 Dec; 178(5-6):465-70.Mycopathologia2014-08-03T00:00:002014A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case.25287755Askew DS, Kontoyiannis DP, Clemons KVMycopathologiaAdvances against aspergillosis: biology, host response, diagnosis and treatment. Mycopathologia. 2014 Dec; 178(5-6):321-4.Mycopathologia2014-10-07T00:00:002014Advances against aspergillosis: biology, host response, diagnosis and treatment.25340258Farmakiotis D, Tarrand JJ, Kontoyiannis DPEmerging infectious diseasesDrug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis. 2014 Nov; 20(11):1833-40.Emerg Infect Dis2014-11-01T00:00:002014Drug-resistant Candida glabrata infection in cancer patients.25352631Kontoyiannis DP, Patterson TFClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaDiagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions. Clin Infect Dis. 2014 Nov 15; 59 Suppl 5:S356-9.Clin Infect Dis2014-11-15T00:00:002014Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.25475924Walsh TJ, Skiada A, Cornely OA, Roilides E, Ibrahim A, Zaoutis T, Groll A, Lortholary O, Kontoyiannis DP, Petrikkos GMycosesDevelopment of new strategies for early diagnosis of mucormycosis from bench to bedside. Mycoses. 2014 Dec; 57 Suppl 3:2-7.Mycoses2014-12-01T00:00:002014Development of new strategies for early diagnosis of mucormycosis from bench to bedside.25056961Simitsopoulou M, Walsh TJ, Kyrpitzi D, Petraitis V, Kontoyiannis DP, Perlin DS, Roilides EMedical mycologyMethylprednisolone impairs conidial phagocytosis but does not attenuate hyphal damage by neutrophils against Exserohilum rostratum. Med Mycol. 2015 Feb 01; 53(2):189-93.Med Mycol2014-07-23T00:00:002014Methylprednisolone impairs conidial phagocytosis but does not attenuate hyphal damage by neutrophils against Exserohilum rostratum.25455847Raad II, Zakhem AE, Helou GE, Jiang Y, Kontoyiannis DP, Hachem RInternational journal of antimicrobial agentsClinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Int J Antimicrob Agents. 2015 Mar; 45(3):283-8.Int J Antimicrob Agents2014-10-12T00:00:002014Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.25539148Miller AO, Gamaletsou MN, Henry MW, Al-Hafez L, Hussain K, Sipsas NV, Kontoyiannis DP, Roilides E, Brause BD, Walsh TJInfectious diseases (London, England)Successful treatment of Candida osteoarticular infections with limited duration of antifungal therapy and orthopedic surgical intervention. Infect Dis (Lond). 2015 Mar; 47(3):144-9.Infect Dis (Lond)2014-12-24T00:00:002014Successful treatment of Candida osteoarticular infections with limited duration of antifungal therapy and orthopedic surgical intervention.25583768Torres HA, Mahale P, Blechacz B, Miller E, Kaseb A, Herlong HF, Fowler N, Jiang Y, Raad II, Kontoyiannis DPJournal of the National Comprehensive Cancer Network : JNCCNEffect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Netw. 2015 Jan; 13(1):41-50.J Natl Compr Canc Netw2015-01-01T00:00:002015Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population.25586686Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PGClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaT2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015 Mar 15; 60(6):892-9.Clin Infect Dis2015-01-12T00:00:002015T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.25599346Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, Heinz WJ, Jagannatha S, Koh LP, Kontoyiannis DP, Lee DG, Nucci M, Pappas PG, Slavin MA, Queiroz-Telles F, Selleslag D, Walsh TJ, Wingard JR, Maertens JAAnnals of internal medicineCombination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015 Jan 20; 162(2):81-9.Ann Intern Med2015-01-20T00:00:002015Combination antifungal therapy for invasive aspergillosis: a randomized trial.25738758Zanette RA, Bitencourt PE, Kontoyiannis DP, Fighera RA, Flores MM, Kommers GD, Silva PS, Ludwig A, Moretto MB, Alves SH, Santurio JMPloS oneComplex interaction of deferasirox and Pythium insidiosum: iron-dependent attenuation of growth in vitro and immunotherapy-like enhancement of immune responses in vivo. PLoS One. 2015; 10(3):e0118932.PLoS One2015-03-04T00:00:002015Complex interaction of deferasirox and Pythium insidiosum: iron-dependent attenuation of growth in vitro and immunotherapy-like enhancement of immune responses in vivo.25830548Shirazi F, Kontoyiannis DP, Ibrahim ASVirulenceIron starvation induces apoptosis in Rhizopus oryzae in vitro. Virulence. 2015; 6(2):121-6.Virulence2015-01-01T00:00:002015Iron starvation induces apoptosis in Rhizopus oryzae in vitro.1400 Pressler StHouston77030-4008TXAuthorship 1656681Authorship 1693121Authorship 1696263Authorship 1696331Authorship 1697544Authorship 1697618Authorship 1699471Authorship 1702353Authorship 17089810Authorship 1709204Authorship 1711655Authorship 1712341Authorship 1712487Authorship 1712636Authorship 1712831Authorship 1716335Authorship 1716769Authorship 1717779Authorship 17221912Authorship 1723177Authorship 1723205Authorship 1724421Authorship 1724587Authorship 17247011Authorship 1727981Authorship 1729312Authorship 1729941Authorship 1729982Authorship 1730653Authorship 1731674Authorship 1732191Authorship 1733414Authorship 1733841Authorship 1734284Authorship 1734363Authorship 1734515Authorship 1734674Authorship 1736322Authorship 1737813Authorship 1738276Authorship 1739071Authorship 1739834Authorship 1741351Authorship 1742106Authorship 1742332Authorship 1742767Authorship 1742941Authorship 1743423Authorship 1743596Authorship 1745579Authorship 1745942Authorship 1746843Authorship 1747724Authorship 1748541Authorship 1749424Authorship 1750022Authorship 1750282Authorship 1750703Authorship 1751015Authorship 1752151Authorship 1752456Authorship 1754265Authorship 1756455Authorship 17573411Authorship 1757848Authorship 17583511Authorship 1758903Authorship 1758984Authorship 1759927Authorship 1760642Authorship 1761467Authorship 1762079Authorship 17621764Authorship 1762181Authorship 1762477Authorship 1764082Authorship 1764382Authorship 1764985Authorship 1765392Authorship 1765732Authorship 1767062Authorship 1769304Authorship 1769411Authorship 1769936Authorship 1771324Authorship 1772707Authorship 1773177Authorship 1773675Authorship 1773693Authorship 17743817Authorship 1775433Authorship 1777444Authorship 1781202Authorship 1781481Authorship 1782451Authorship 1785801Authorship 1786293Authorship 1787184Authorship 1788773Authorship 1789235Authorship 1790756Authorship 1790855Authorship 1792993Authorship 1794006Authorship 1794586Authorship 1794802Authorship 1795494Authorship 1795501Authorship 1796864Authorship 1797655Authorship 1797972Authorship 1798228Authorship 1798404Authorship 1798953Authorship 1799682Authorship 18024611Authorship 1804185Authorship 18044919Authorship 1805668Authorship 1805732Authorship 1806043Authorship 1806902Authorship 1807395Authorship 1808382Authorship 1808405Authorship 1811473Authorship 18133915Authorship 1814713Authorship 1814886Authorship 1815433Authorship 1816775Authorship 1816874Authorship 1816958Authorship 1817134Authorship 1817493Authorship 1817771Authorship 1818387Authorship 1818534Authorship 1821985Authorship 1822121Authorship 1822885Authorship 1822954Authorship 1823355Authorship 1825847Authorship 1826117Authorship 1828141Authorship 1828326Authorship 1828483Authorship 1830484Authorship 1830726Authorship 18312411Authorship 1832584Authorship 1833034Authorship 18336111Authorship 1836392Authorship 18377010Authorship 1839268Authorship 1841474Authorship 1841522Authorship 1843816Authorship 1843871Authorship 1845111Authorship 1845638Authorship 1846593Authorship 1847688Authorship 1850312Authorship 1850373Authorship 1851204Authorship 1852852Authorship 1854342Authorship 1854533Authorship 1858014Authorship 1858135Authorship 1858613Authorship 1858982Authorship 1859893Authorship 1860018Authorship 1860813Authorship 1862442Authorship 1863371Authorship 1864537Authorship 1865766Authorship 1865898Authorship 1866984Authorship 1867123Authorship 1868512Authorship 1868635Authorship 1868691Authorship 1869641Authorship 1869657Authorship 1871136Authorship 1872141Authorship 1872634Authorship 1873274Authorship 1873401Authorship 1876163Authorship 1876204Authorship 1876462Authorship 1876816Authorship 1878731Authorship 1878792Authorship 1879044Authorship 1879715Authorship 1879788Authorship 1879792Authorship 1880115Authorship 1880392Authorship 1880932Authorship 1881083Authorship 1881975Authorship 1881987Authorship 1881991Authorship 1883953Authorship 1883964Authorship 1883976Authorship 1885553Authorship 1886752Authorship 1887514Authorship 18890218Authorship 1889102Authorship 1889222Authorship 1889865Authorship 18925125Authorship 1892902Authorship 1893012Authorship 1894655Authorship 1895424Authorship 18955911Authorship 1898445Authorship 1898457Authorship 1899083Authorship 1899402Authorship 1901094Authorship 1901222Authorship 1902331Authorship 1902701Authorship 19049010Authorship 1905373Authorship 1906012Authorship 1906675Authorship 1906881Authorship 1906924Authorship 1908162Authorship 1909872Authorship 1910112Authorship 1910762Authorship 1911194Authorship 1912605Authorship 1912926Authorship 1913016Authorship 1913081Authorship 1913843Authorship 1914132Authorship 1914306Authorship 1917181Authorship 1917385Authorship 1920973Authorship 1923185Authorship 1925813Authorship 1926362Authorship 1928148Authorship 1928402Authorship 1929076Authorship 1930732Authorship 1932863Authorship 1933439Authorship 1933845Authorship 1935281Authorship 1935605Authorship 1935645Authorship 1937019Authorship 1937552Authorship 1940604Authorship 1941107Authorship 1942144Authorship 1944611Authorship 19451516Authorship 1947026Authorship 1947031Authorship 1949004Authorship 1949472Authorship 1950147Authorship 1955721Authorship 1956041Authorship 19560810Authorship 1957411Authorship 1957882Authorship 1959396Authorship 1959766Authorship 1960932Authorship 1961451Authorship 1962222Infectious Diseases, Infection Control, and Employee HealthLaboratory MedicineLeukemiaStem Cell TransplantationMD AndersonRICHARD ECHAMPLINRICHARD E CHAMPLIN8508CHAMPLIN, RICHARD EProfessorISSAM IRAADISSAM I RAAD8617RAAD, ISSAM IProfessor41.41280.006630071085research areas5.999010.0143788152coauthor of815.50881.186360similar to11608selected publicationsHARRYS ANTONIOTORRESHARRYS ANTONIO TORRES8947TORRES, HARRYS ANTONIOAssociate ProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorRAY YHACHEMRAY Y HACHEM8572HACHEM, RAY YProfessorVICTOR EDUARDOMULANOVICHVICTOR EDUARDO MULANOVICH9330MULANOVICH, VICTOR EDUARDOProfessorARIEL DAVIDSZVALBARIEL DAVID SZVALB9747SZVALB, ARIEL DAVIDAssistant ProfessorJEFFREY JTARRANDJEFFREY J TARRAND8433TARRAND, JEFFREY JProfessorAuthorship 24762816170771Pagano L, Gleissner B, Fianchi LThe Journal of infectious diseasesBreakthrough zygomycosis and voriconazole. J Infect Dis. 2005 Oct 15; 192(8):1496-7; author reply 1497.J Infect Dis2005-10-15T00:00:002005Breakthrough zygomycosis and voriconazole.25377139Kontoyiannis DP, Lewis RECold Spring Harbor perspectives in medicineTreatment principles for the management of mold infections. Cold Spring Harb Perspect Med. 2014 Nov 06; 5(4).Cold Spring Harb Perspect Med2014-11-06T00:00:002014Treatment principles for the management of mold infections.26000646Ananda-Rajah MR, Kontoyiannis DFuture microbiologyIsavuconazole: a new extended spectrum triazole for invasive mold diseases. Future Microbiol. 2015; 10(5):693-708.Future Microbiol2015-05-21T00:00:002015Isavuconazole: a new extended spectrum triazole for invasive mold diseases.Authorship 2805281Authorship 2806209Authorship 2806477Authorship 2806582Authorship 2806632Authorship 2806702Authorship 2806957Authorship 2806971Authorship 2807062Authorship 2807093Authorship 2807404Authorship 2807471Authorship 2807643Authorship 2807805Authorship 2807851Authorship 2808339Authorship 2808472Authorship 2808532Authorship 28090210Authorship 28090310Authorship 28091313Authorship 2809155Authorship 2809175Authorship 2809183Authorship 2809287Authorship 2809343Authorship 2809422Authorship 2809852Authorship 2809914Authorship 2810041Authorship 2810095Authorship 28105968288685Kontoyiannis DP, Olivero JJHospital practice (Office ed.)Intestinal obstruction in a dialysis patient with a broken leg. Hosp Pract (Off Ed). 1994 Jan 15; 29(1):133-4.Hosp Pract (Off Ed)1994-01-15T00:00:001994Intestinal obstruction in a dialysis patient with a broken leg.Authorship 2942895Authorship 2954856Authorship 29566912Authorship 2981704Authorship 2985853Authorship 2994975Authorship 2996554Authorship 30057119Authorship 3012254Authorship 3019188Authorship 3022687Authorship 3024626Authorship 30334013Authorship 3043742Authorship 3056518Authorship 305896625855759Wang E, Farmakiotis D, Yang D, McCue DA, Kantarjian HM, Kontoyiannis DP, Mathisen MSThe Journal of antimicrobial chemotherapyThe ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. J Antimicrob Chemother. 2015 Aug; 70(8):2362-8.J Antimicrob Chemother2015-04-07T00:00:002015The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality.25908651McCarty TP, Baddley JW, Walsh TJ, Alexander BD, Kontoyiannis DP, Perl TM, Walker R, Patterson TF, Schuster MG, Lyon GM, Wingard JR, Andes DR, Park BJ, Brandt ME, Pappas PG, TRANSNET InvestigatorsMedical mycologyPhaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET). Med Mycol. 2015 Jun; 53(5):440-6.Med Mycol2015-04-23T00:00:002015Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).25944341Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PGClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaReply to Bauer and Goff. Clin Infect Dis. 2015 Aug 01; 61(3):487-8.Clin Infect Dis2015-05-05T00:00:002015Reply to Bauer and Goff.26100603Chitasombat MN, Kontoyiannis DPExpert opinion on pharmacotherapyThe 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections. Expert Opin Pharmacother. 2015; 16(10):1543-58.Expert Opin Pharmacother2015-06-23T00:00:002015The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections.26107507Neofytos D, Railkar R, Mullane KM, Fredricks DN, Granwehr B, Marr KA, Almyroudis NG, Kontoyiannis DP, Maertens J, Fox R, Douglas C, Iannone R, Kauh E, Shire NPloS oneCorrelation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis. PLoS One. 2015; 10(6):e0129022.PLoS One2015-06-24T00:00:002015Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.26149982Mircus G, Albert N, Ben-Yaakov D, Chikvashvili D, Shadkchan Y, Kontoyiannis DP, Osherov NAntimicrobial agents and chemotherapyIdentification and characterization of a novel family of selective antifungal compounds (CANBEFs) that interfere with fungal protein synthesis. Antimicrob Agents Chemother. 2015 Sep; 59(9):5631-40.Antimicrob Agents Chemother2015-07-06T00:00:002015Identification and characterization of a novel family of selective antifungal compounds (CANBEFs) that interfere with fungal protein synthesis.26168081Meller S, Di Domizio J, Voo KS, Friedrich HC, Chamilos G, Ganguly D, Conrad C, Gregorio J, Le Roy D, Roger T, Ladbury JE, Homey B, Watowich S, Modlin RL, Kontoyiannis DP, Liu YJ, Arold ST, Gilliet MNature immunologyT(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26. Nat Immunol. 2015 Sep; 16(9):970-9.Nat Immunol2015-07-13T00:00:002015T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26.26242966Throckmorton K, Lim FY, Kontoyiannis DP, Zheng W, Keller NPEnvironmental microbiologyRedundant synthesis of a conidial polyketide by two distinct secondary metabolite clusters in Aspergillus fumigatus. Environ Microbiol. 2016 Jan; 18(1):246-59.Environ Microbiol2015-09-03T00:00:002015Redundant synthesis of a conidial polyketide by two distinct secondary metabolite clusters in Aspergillus fumigatus.26311837Jung DS, Tverdek FP, Jiang Y, Kontoyiannis DPThe Journal of antimicrobial chemotherapySwitching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests. J Antimicrob Chemother. 2015 Nov; 70(11):3100-6.J Antimicrob Chemother2015-08-25T00:00:002015Switching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests.26392499Bellanger AP, Albert ND, Lewis RE, Walsh TJ, Kontoyiannis DPAntimicrobial agents and chemotherapyEffect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae. Antimicrob Agents Chemother. 2015 Dec; 59(12):7830-2.Antimicrob Agents Chemother2015-09-21T00:00:002015Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.26488845Jung DS, Farmakiotis D, Jiang Y, Tarrand JJ, Kontoyiannis DPEmerging infectious diseasesUncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA. Emerg Infect Dis. 2015 Nov; 21(11):1942-50.Emerg Infect Dis2015-11-01T00:00:002015Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA.26504183Halpern AB, Lyman GH, Walsh TJ, Kontoyiannis DP, Walter RBBloodPrimary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. Blood. 2015 Dec 24; 126(26):2790-7.Blood2015-10-26T00:00:002015Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.26556047Shelburne SA, Ajami NJ, Chibucos MC, Beird HC, Tarrand J, Galloway-Pe?a J, Albert N, Chemaly RF, Ghantoji SS, Marsh L, Pemmaraju N, Andreeff M, Shpall EJ, Wargo JA, Rezvani K, Alousi A, Bruno VM, Futreal PA, Petrosino JF, Kontoyiannis DPPloS oneImplementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis. PLoS One. 2015; 10(11):e0139851.PLoS One2015-11-10T00:00:002015Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis.26619165Georgiadou SP, Pongas G, Fitzgerald NE, Lewis RE, Rytting M, Marom EM, Kontoyiannis DPJournal of the Pediatric Infectious Diseases SocietyInvasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: A 10-Year, Single-Institution, Retrospective Study. J Pediatric Infect Dis Soc. 2012 Jun; 1(2):125-35.J Pediatric Infect Dis Soc2012-05-03T00:00:002012Invasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: A 10-Year, Single-Institution, Retrospective Study.26683917Taj-Aldeen SJ, Rammaert B, Gamaletsou M, Sipsas NV, Zeller V, Roilides E, Kontoyiannis DP, Miller AO, Petraitis V, Walsh TJ, Lortholary O, International Osteoarticular Mycoses ConsortiumMedicineOsteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review. Medicine (Baltimore). 2015 Dec; 94(50):e2078.Medicine (Baltimore)2015-12-01T00:00:002015Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review.26749442Akoumianaki T, Kyrmizi I, Valsecchi I, Gresnigt MS, Samonis G, Drakos E, Boumpas D, Muszkieta L, Prevost MC, Kontoyiannis DP, Chavakis T, Netea MG, van de Veerdonk FL, Brakhage AA, El-Benna J, Beauvais A, Latge JP, Chamilos GCell host & microbeAspergillus Cell Wall Melanin Blocks LC3-Associated Phagocytosis to Promote Pathogenicity. Cell Host Microbe. 2016 Jan 13; 19(1):79-90.Cell Host Microbe2015-12-31T00:00:002015Aspergillus Cell Wall Melanin Blocks LC3-Associated Phagocytosis to Promote Pathogenicity.11774088Kontoyiannis DP, Reddy BT, Torres HA, Luna M, Lewis RE, Tarrand J, Bodey GP, Raad IIClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis. 2002 Feb 01; 34(3):400-3.Clin Infect Dis2001-12-17T00:00:002001Pulmonary candidiasis in patients with cancer: an autopsy study.11928852Reddy BT, Torres HA, Kontoyiannis DPScandinavian journal of infectious diseasesBreast implant infection caused by Trichosporon beigelii. Scand J Infect Dis. 2002; 34(2):143-4.Scand J Infect Dis2002-01-01T00:00:002002Breast implant infection caused by Trichosporon beigelii.12234846Lewis RE, Prince RA, Chi J, Kontoyiannis DPAntimicrobial agents and chemotherapyItraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2002 Oct; 46(10):3208-14.Antimicrob Agents Chemother2002-10-01T00:00:002002Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.12269452Raad I, Tarrand J, Hanna H, Albitar M, Janssen E, Boktour M, Bodey G, Mardani M, Hachem R, Kontoyiannis D, Whimbey E, Rolston KInfection control and hospital epidemiologyEpidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol. 2002 Sep; 23(9):532-7.Infect Control Hosp Epidemiol2002-09-01T00:00:002002Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer.12399756Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem R, Raad IJournal of the American Academy of DermatologySkin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002 Nov; 47(5):659-66.J Am Acad Dermatol2002-11-01T00:00:002002Skin lesions associated with Fusarium infection.12660121Kontoyiannis DP, Mantadakis E, Samonis GThe Journal of hospital infectionSystemic mycoses in the immunocompromised host: an update in antifungal therapy. J Hosp Infect. 2003 Apr; 53(4):243-58.J Hosp Infect2003-04-01T00:00:002003Systemic mycoses in the immunocompromised host: an update in antifungal therapy.12872348Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad IICancerEfficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 2003 Jul 15; 98(2):292-9.Cancer2003-07-15T00:00:002003Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies.14530780Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DPMedicineCandidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore). 2003 Sep; 82(5):309-21.Medicine (Baltimore)2003-09-01T00:00:002003Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.14567605Han XY, Weinberg JS, Prabhu SS, Hassenbusch SJ, Fuller GN, Tarrand JJ, Kontoyiannis DPJournal of neurosurgeryFusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis. J Neurosurg. 2003 Oct; 99(4):693-700.J Neurosurg2003-10-01T00:00:002003Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis.14624103Antoniadou A, Kontoyiannis DPCurrent opinion in infectious diseasesStatus of combination therapy for refractory mycoses. Curr Opin Infect Dis. 2003 Dec; 16(6):539-45.Curr Opin Infect Dis2003-12-01T00:00:002003Status of combination therapy for refractory mycoses.14745874Mattiuzzi GN, Kantarjian H, O'Brien S, Kontoyiannis DP, Giles F, Zhou X, Lim J, Bekele BN, Faderl S, Cortes J, Pierce S, Leitz GJ, Raad I, Estey ECancerIntravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy. Cancer. 2004 Feb 01; 100(3):568-73.Cancer2004-02-01T00:00:002004Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy.15095217Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, Mardani M, Kontoyiannis D, Darouiche R, Hachem R, Bodey GPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaManagement of central venous catheters in patients with cancer and candidemia. Clin Infect Dis. 2004 Apr 15; 38(8):1119-27.Clin Infect Dis2004-03-26T00:00:002004Management of central venous catheters in patients with cancer and candidemia.11941561Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaWhy prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis. Clin Infect Dis. 2002 May 01; 34(9):1281-3; author reply 1283.Clin Infect Dis2002-05-01T00:00:002002Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis.15378439Wiederhold NP, Kontoyiannis DP, Chi J, Prince RA, Tam VH, Lewis REThe Journal of infectious diseasesPharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. J Infect Dis. 2004 Oct 15; 190(8):1464-71.J Infect Dis2004-09-10T00:00:002004Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity.15452832Ohmagari N, Raad II, Hachem R, Kontoyiannis DPCancerInvasive aspergillosis in patients with solid tumors. Cancer. 2004 Nov 15; 101(10):2300-2.Cancer2004-11-15T00:00:002004Invasive aspergillosis in patients with solid tumors.15489926Liu W, May GS, Kontoyiannis DP, Li RYBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences[Cloning of the Aspergillus fumigatus squalene epoxidase gene]. Beijing Da Xue Xue Bao Yi Xue Ban. 2004 Oct; 36(5):476-82.Beijing Da Xue Xue Bao Yi Xue Ban2004-10-01T00:00:002004[Cloning of the Aspergillus fumigatus squalene epoxidase gene].15618207Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP, Prince RAInfection and immunityDetection of gliotoxin in experimental and human aspergillosis. Infect Immun. 2005 Jan; 73(1):635-7.Infect Immun2005-01-01T00:00:002005Detection of gliotoxin in experimental and human aspergillosis.74Professor10Assistant Professor14Associate Professor15641032Safdar A, Rodriguez G, Ohmagari N, Kontoyiannis DP, Rolston KV, Raad II, Champlin RECancerThe safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. Cancer. 2005 Feb 15; 103(4):731-9.Cancer2005-02-15T00:00:002005The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation.15673808Kontoyiannis DP, Lewis REThe New England journal of medicineCaspofungin versus liposomal amphotericin B for empirical therapy. N Engl J Med. 2005 Jan 27; 352(4):410-4; author reply 410-4.N Engl J Med2005-01-27T00:00:002005Caspofungin versus liposomal amphotericin B for empirical therapy.15747256Lionakis MS, Lewis RE, May GS, Wiederhold NP, Albert ND, Halder G, Kontoyiannis DPThe Journal of infectious diseasesToll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. J Infect Dis. 2005 Apr 01; 191(7):1188-95.J Infect Dis2005-02-28T00:00:002005Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence.15844093Kontoyiannis DP, Boktour M, Hanna H, Torres HA, Hachem R, Raad IICancerItraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer. 2005 Jun 01; 103(11):2334-7.Cancer2005-06-01T00:00:002005Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.11897612Lewis RE, Lo HJ, Raad II, Kontoyiannis DPAntimicrobial agents and chemotherapyLack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth. Antimicrob Agents Chemother. 2002 Apr; 46(4):1153-5.Antimicrob Agents Chemother2002-04-01T00:00:002002Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth.11904112Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, Hachem RY, Kontoyiannis DP, Raad IIThe American journal of medicineThe epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med. 2002 Apr 01; 112(5):380-5.Am J Med2002-04-01T00:00:002002The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.11943280Kontoyiannis DP, Lewis RELancet (London, England)Antifungal drug resistance of pathogenic fungi. Lancet. 2002 Mar 30; 359(9312):1135-44.Lancet2002-03-30T00:00:002002Antifungal drug resistance of pathogenic fungi.12801355Kontoyiannis DPMycosesWhat is the significance of an isolated positive cryptococcal antigen in the cerebrospinal fluid of cancer patients? Mycoses. 2003 Jun; 46(5-6):161-3.Mycoses2003-06-01T00:00:002003What is the significance of an isolated positive cryptococcal antigen in the cerebrospinal fluid of cancer patients?11997717Torres HA, Rivero GA, Kontoyiannis DPMedicineEndemic mycoses in a cancer hospital. Medicine (Baltimore). 2002 May; 81(3):201-12.Medicine (Baltimore)2002-05-01T00:00:002002Endemic mycoses in a cancer hospital.16439177Rolston KV, Yadegarynia D, Kontoyiannis DP, Raad II, Ho DHInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious DiseasesThe spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients. Int J Infect Dis. 2006 May; 10(3):223-30.Int J Infect Dis2006-01-24T00:00:002006The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.26612873Aitken SL, Zhou J, Ghantoji SS, Kontoyiannis DP, Jones RB, Tam VH, Chemaly RFThe Journal of antimicrobial chemotherapyPharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients. J Antimicrob Chemother. 2016 Mar; 71(3):727-30.J Antimicrob Chemother2015-11-26T00:00:002015Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.27142181Galloway-Pe?a JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SACancerThe role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer. 2016 07 15; 122(14):2186-96.Cancer2016-05-03T00:00:002016The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.16609347Yusuf SW, Ali SS, Swafford J, Durand JB, Bodey GP, Chemaly RF, Kontoyiannis DP, Tarrand J, Rolston KV, Yeh E, Raad II, Safdar AMedicineCulture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004. Medicine (Baltimore). 2006 Mar; 85(2):86-94.Medicine (Baltimore)2006-03-01T00:00:002006Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004.16619151Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPosaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis. 2006 May 15; 42(10):1398-403.Clin Infect Dis2006-04-11T00:00:002006Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.16640816Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RFClinical lymphoma & myelomaCytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006 Mar; 6(5):393-8.Clin Lymphoma Myeloma2006-03-01T00:00:002006Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality.16804387Chamilos G, Kontoyiannis DPCurrent opinion in infectious diseasesThe rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine. Curr Opin Infect Dis. 2006 Aug; 19(4):380-5.Curr Opin Infect Dis2006-08-01T00:00:002006The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine.14576123Liu W, Lionakis MS, Lewis RE, Wiederhold N, May GS, Kontoyiannis DPAntimicrobial agents and chemotherapyAttenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole. Antimicrob Agents Chemother. 2003 Nov; 47(11):3592-7.Antimicrob Agents Chemother2003-11-01T00:00:002003Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.16983616Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis TClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaClinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis. 2006 Oct 15; 43(8):1031-9.Clin Infect Dis2006-09-13T00:00:002006Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.14643296Kontoyiannis DP, Lewis REDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapyCombination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Drug Resist Updat. 2003 Oct; 6(5):257-69.Drug Resist Updat2003-10-01T00:00:002003Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far.17083020Almyroudis NG, Kontoyiannis DP, Sepkowitz KA, DePauw BE, Walsh TJ, Segal BHClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaIssues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection. Clin Infect Dis. 2006 Dec 01; 43(11):1449-55.Clin Infect Dis2006-10-20T00:00:002006Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection.17109292Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaScedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis. 2006 Dec 15; 43(12):1580-4.Clin Infect Dis2006-11-09T00:00:002006Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006.14692037Lionakis MS, Kontoyiannis DPCancerThe significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer. Cancer. 2004 Jan 01; 100(1):165-72.Cancer2004-01-01T00:00:002004The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer.12518369Mattiuzzi GN, Estey E, Raad I, Giles F, Cortes J, Shen Y, Kontoyiannis D, Koller C, Munsell M, Beran M, Kantarjian HCancerLiposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome. Cancer. 2003 Jan 15; 97(2):450-6.Cancer2003-01-15T00:00:002003Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.12520695Pham AS, Tarrand JJ, May GS, Lee MS, Kontoyiannis DP, Han XYAmerican journal of clinical pathologyDiagnosis of invasive mold infection by real-time quantitative PCR. Am J Clin Pathol. 2003 Jan; 119(1):38-44.Am J Clin Pathol2003-01-01T00:00:002003Diagnosis of invasive mold infection by real-time quantitative PCR.14695039Wiederhold NP, Lewis RE, Kontoyiannis DPPharmacotherapyInvasive aspergillosis in patients with hematologic malignancies. Pharmacotherapy. 2003 Dec; 23(12):1592-610.Pharmacotherapy2003-12-01T00:00:002003Invasive aspergillosis in patients with hematologic malignancies.12562696Kontoyiannis DP, Lewis RE, Osherov N, Albert ND, May GSThe Journal of antimicrobial chemotherapyCombination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J Antimicrob Chemother. 2003 Feb; 51(2):313-6.J Antimicrob Chemother2003-02-01T00:00:002003Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.14745876Mattiuzzi GN, Kantarjian H, Faderl S, Lim J, Kontoyiannis D, Thomas D, Wierda W, Raad I, Garcia-Manero G, Zhou X, Ferrajoli A, Bekele N, Estey ECancerAmphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy. Cancer. 2004 Feb 01; 100(3):581-9.Cancer2004-02-01T00:00:002004Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.17261624Lewis RE, Liao G, Hou J, Chamilos G, Prince RA, Kontoyiannis DPAntimicrobial agents and chemotherapyComparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2007 Apr; 51(4):1253-8.Antimicrob Agents Chemother2007-01-29T00:00:002007Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.17438060Chamilos G, Lewis RE, Albert N, Kontoyiannis DPAntimicrobial agents and chemotherapyParadoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences. Antimicrob Agents Chemother. 2007 Jun; 51(6):2257-9.Antimicrob Agents Chemother2007-04-16T00:00:002007Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.17581930Lass-Fl?rl C, Grif K, Kontoyiannis DPJournal of clinical microbiologyMolecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol. 2007 Aug; 45(8):2686-90.J Clin Microbiol2007-06-20T00:00:002007Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity.17614303Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II, Manning JT, Han XCancerIncreased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer. 2007 Sep 15; 110(6):1303-6.Cancer2007-09-15T00:00:002007Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation.12733157Hicks KL, Chemaly RF, Kontoyiannis DPCancerCommon community respiratory viruses in patients with cancer: more than just "common colds". Cancer. 2003 May 15; 97(10):2576-87.Cancer2003-05-15T00:00:002003Common community respiratory viruses in patients with cancer: more than just "common colds".12737884Kontoyiannis DP, Pasqualini R, Arap WLancet (London, England)Aminopeptidase N inhibitors and SARS. Lancet. 2003 May 03; 361(9368):1558.Lancet2003-05-03T00:00:002003Aminopeptidase N inhibitors and SARS.12801359Kontoyiannis DP, Murray PJMycosesFluconazole toxicity is independent of oxidative stress and apoptotic effector mechanisms in Saccharomyces cerevisiae. Mycoses. 2003 Jun; 46(5-6):183-6.Mycoses2003-06-01T00:00:002003Fluconazole toxicity is independent of oxidative stress and apoptotic effector mechanisms in Saccharomyces cerevisiae.12833460Torres HA, Bodey GP, Rolston KV, Kantarjian HM, Raad II, Kontoyiannis DPCancerInfections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer. 2003 Jul 01; 98(1):86-93.Cancer2003-07-01T00:00:002003Infections in patients with aplastic anemia: experience at a tertiary care cancer center.15238137Kontoyiannis DP, Lewis REBritish journal of haematologyToward more effective antifungal therapy: the prospects of combination therapy. Br J Haematol. 2004 Jul; 126(2):165-75.Br J Haematol2004-07-01T00:00:002004Toward more effective antifungal therapy: the prospects of combination therapy.12910522Ferrajoli A, O'Brien SM, Cortes JE, Giles FJ, Thomas DA, Faderl S, Kurzrock R, Lerner S, Kontoyiannis DP, Keating MJCancerPhase II study of alemtuzumab in chronic lymphoproliferative disorders. Cancer. 2003 Aug 15; 98(4):773-8.Cancer2003-08-15T00:00:002003Phase II study of alemtuzumab in chronic lymphoproliferative disorders.12942573Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KVCancerTreatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer. 2003 Sep 01; 98(5):1039-47.Cancer2003-09-01T00:00:002003Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.18419427Wahba H, Truong MT, Lei X, Kontoyiannis DP, Marom EMClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaReversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis. 2008 Jun 01; 46(11):1733-7.Clin Infect Dis2008-06-01T00:00:002008Reversed halo sign in invasive pulmonary fungal infections.18444808Awais A, Tam CS, Kontoyiannis D, Ferrajoli A, Duvic M, Cortes J, Keating MJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaRapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia. Clin Infect Dis. 2008 Apr 01; 46(7):e69-71.Clin Infect Dis2008-04-01T00:00:002008Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia.15378491Hachem RY, Kontoyiannis DP, Boktour MR, Afif C, Cooksley C, Bodey GP, Chatzinikolaou I, Perego C, Kantarjian HM, Raad IICancerAspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer. 2004 Oct 01; 101(7):1594-600.Cancer2004-10-01T00:00:002004Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.18611163Chamilos G, Lewis RE, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaDelaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008 Aug 15; 47(4):503-9.Clin Infect Dis2008-08-15T00:00:002008Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.18845827Kasai M, Harrington SM, Francesconi A, Petraitis V, Petraitiene R, Beveridge MG, Knudsen T, Milanovich J, Cotton MP, Hughes J, Schaufele RL, Sein T, Bacher J, Murray PR, Kontoyiannis DP, Walsh TJJournal of clinical microbiologyDetection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol. 2008 Nov; 46(11):3690-702.J Clin Microbiol2008-09-24T00:00:002008Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis.15585989Karatzi K, Papamichael C, Aznaouridis K, Karatzis E, Lekakis J, Matsouka C, Boskou G, Chiou A, Sitara M, Feliou G, Kontoyiannis D, Zampelas A, Mavrikakis MCoronary artery diseaseConstituents of red wine other than alcohol improve endothelial function in patients with coronary artery disease. Coron Artery Dis. 2004 Dec; 15(8):485-90.Coron Artery Dis2004-12-01T00:00:002004Constituents of red wine other than alcohol improve endothelial function in patients with coronary artery disease.18983417Kontoyiannis DP, Ratanatharathorn V, Young JA, Raymond J, Laverdi?re M, Denning DW, Patterson TF, Facklam D, Kovanda L, Arnold L, Lau W, Buell D, Marr KATransplant infectious disease : an official journal of the Transplantation SocietyMicafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis. Transpl Infect Dis. 2009 Feb; 11(1):89-93.Transpl Infect Dis2008-10-08T00:00:002008Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.19180749Atkinson BJ, Lewis RE, Kontoyiannis DPMedical mycologyCandida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol. 2008 Sep; 46(6):541-6.Med Mycol2008-09-01T00:00:002008Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome.19267655Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPhaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis. 2009 Apr 15; 48(8):1033-41.Clin Infect Dis2009-04-15T00:00:002009Phaeohyphomycosis in a tertiary care cancer center.19329554Evans SE, Scott BL, Clement CG, Larson DT, Kontoyiannis D, Lewis RE, Lasala PR, Pawlik J, Peterson JW, Chopra AK, Klimpel G, Bowden G, H??k M, Xu Y, Tuvim MJ, Dickey BFAmerican journal of respiratory cell and molecular biologyStimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am J Respir Cell Mol Biol. 2010 Jan; 42(1):40-50.Am J Respir Cell Mol Biol2009-03-27T00:00:002009Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi.19358672Lamaris GA, Ben-Ami R, Lewis RE, Chamilos G, Samonis G, Kontoyiannis DPThe Journal of infectious diseasesIncreased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J Infect Dis. 2009 May 01; 199(9):1399-406.J Infect Dis2009-05-01T00:00:002009Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.15766609Rolston KV, Kontoyiannis DP, Yadegarynia D, Raad IIDiagnostic microbiology and infectious diseaseNonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones. Diagn Microbiol Infect Dis. 2005 Mar; 51(3):215-8.Diagn Microbiol Infect Dis2005-03-01T00:00:002005Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones.19675215Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, Andes D, Kontoyiannis DP, Perrone G, Peterson S, Brandt ME, Pappas PG, Chiller TJournal of clinical microbiologyMolecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009 Oct; 47(10):3138-41.J Clin Microbiol2009-08-12T00:00:002009Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.19836185Ben-Ami R, Lasala PR, Lewis RE, Kontoyiannis DPDiagnostic microbiology and infectious diseaseLack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis. Diagn Microbiol Infect Dis. 2010 Feb; 66(2):200-3.Diagn Microbiol Infect Dis2010-02-01T00:00:002010Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis.19843884Ben-Ami R, Lewis RE, Leventakos K, Kontoyiannis DPBloodAspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites. Blood. 2009 Dec 17; 114(26):5393-9.Blood2009-10-20T00:00:002009Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites.20038620Lewis RE, Albert ND, Liao G, Hou J, Prince RA, Kontoyiannis DPAntimicrobial agents and chemotherapyComparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis. Antimicrob Agents Chemother. 2010 Mar; 54(3):1298-304.Antimicrob Agents Chemother2009-12-28T00:00:002009Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.20109093Milito MA, Kontoyiannis DP, Lewis RE, Liu P, Mawlawi OR, Truong MT, Marom EMMedical mycologyInfluence of host immunosuppression on CT findings in invasive pulmonary aspergillosis. Med Mycol. 2010 Sep; 48(6):817-23.Med Mycol2010-09-01T00:00:002010Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis.20145078Ben-Ami R, Lewis RE, Leventakos K, Latg? JP, Kontoyiannis DPAntimicrobial agents and chemotherapyCutaneous model of invasive aspergillosis. Antimicrob Agents Chemother. 2010 May; 54(5):1848-54.Antimicrob Agents Chemother2010-02-09T00:00:002010Cutaneous model of invasive aspergillosis.20218876Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Perl TM, Oster RA, Schuster MG, Walker R, Walsh TJ, Wannemuehler KA, Chiller TMClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaInvasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010 Apr 15; 50(8):1101-11.Clin Infect Dis2010-04-15T00:00:002010Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).20218877Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PGClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaProspective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010 Apr 15; 50(8):1091-100.Clin Infect Dis2010-04-15T00:00:002010Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.20430790Oxman DA, Chow JK, Frendl G, Hadley S, Hershkovitz S, Ireland P, McDermott LA, Tsai K, Marty FM, Kontoyiannis DP, Golan YThe Journal of antimicrobial chemotherapyCandidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern? J Antimicrob Chemother. 2010 Jul; 65(7):1460-5.J Antimicrob Chemother2010-04-29T00:00:002010Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?20450350Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, Wingard JR, Patterson TF, Ito JI, Williams OD, Chiller T, Pappas PGClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaFactors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis. 2010 Jun 15; 50(12):1559-67.Clin Infect Dis2010-06-15T00:00:002010Factors associated with mortality in transplant patients with invasive aspergillosis.20450414Panackal AA, Li H, Kontoyiannis DP, Mori M, Perego CA, Boeckh M, Marr KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaGeoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2010 Jun 15; 50(12):1588-97.Clin Infect Dis2010-06-15T00:00:002010Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation.20466278Person AK, Kontoyiannis DP, Alexander BDInfectious disease clinics of North AmericaFungal infections in transplant and oncology patients. Infect Dis Clin North Am. 2010 Jun; 24(2):439-59.Infect Dis Clin North Am2010-06-01T00:00:002010Fungal infections in transplant and oncology patients.16188916Lewis RE, Kontoyiannis DPThe Journal of antimicrobial chemotherapyMicafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro. J Antimicrob Chemother. 2005 Nov; 56(5):887-92.J Antimicrob Chemother2005-09-27T00:00:002005Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.20732350Nguyen MH, Husain S, Clancy CJ, Peacock JE, Hung CC, Kontoyiannis DP, Morris AJ, Heath CH, Wagener M, Yu VLThe Journal of infectionOutcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study. J Infect. 2010 Nov; 61(5):419-26.J Infect2010-08-21T00:00:002010Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study.20827189Chen SC, Kontoyiannis DPCurrent opinion in infectious diseasesNew molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Curr Opin Infect Dis. 2010 Dec; 23(6):567-77.Curr Opin Infect Dis2010-12-01T00:00:002010New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients.15365692Xue T, Nguyen CK, Romans A, Kontoyiannis DP, May GSArchives of microbiologyIsogenic auxotrophic mutant strains in the Aspergillus fumigatus genome reference strain AF293. Arch Microbiol. 2004 Nov; 182(5):346-53.Arch Microbiol2004-09-09T00:00:002004Isogenic auxotrophic mutant strains in the Aspergillus fumigatus genome reference strain AF293.15386338Boktour MR, Kontoyiannis DP, Hanna HA, Hachem RY, Girgawy E, Bodey GP, Raad IICancerMultiple-species candidemia in patients with cancer. Cancer. 2004 Oct 15; 101(8):1860-5.Cancer2004-10-15T00:00:002004Multiple-species candidemia in patients with cancer.20956598Lewis RE, Pongas GN, Albert N, Ben-Ami R, Walsh TJ, Kontoyiannis DPAntimicrobial agents and chemotherapyActivity of deferasirox in Mucorales: influences of species and exogenous iron. Antimicrob Agents Chemother. 2011 Jan; 55(1):411-3.Antimicrob Agents Chemother2010-10-18T00:00:002010Activity of deferasirox in Mucorales: influences of species and exogenous iron.16291275Chamilos G, Kontoyiannis DPThe Journal of infectionVoriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis. J Infect. 2005 Nov; 51(4):e225-8.J Infect2005-11-01T00:00:002005Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.16310149Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad IIThe Lancet. Infectious diseasesPosaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005 Dec; 5(12):775-85.Lancet Infect Dis2005-12-01T00:00:002005Posaconazole: a broad-spectrum triazole antifungal.15569782Montes M, White AC, Kontoyiannis DPThe American journal of tropical medicine and hygieneSymptoms of intestinal schistosomiasis presenting during treatment of large B cell lymphoma. Am J Trop Med Hyg. 2004 Nov; 71(5):552-3.Am J Trop Med Hyg2004-11-01T00:00:002004Symptoms of intestinal schistosomiasis presenting during treatment of large B cell lymphoma.21482731Gomes MZ, Lewis RE, Kontoyiannis DPClinical microbiology reviewsMucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011 Apr; 24(2):411-45.Clin Microbiol Rev2011-04-01T00:00:002011Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.15634998Tarrand JJ, Han XY, Kontoyiannis DP, May GSJournal of clinical microbiologyAspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery. J Clin Microbiol. 2005 Jan; 43(1):382-6.J Clin Microbiol2005-01-01T00:00:002005Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery.15666328Sipsas NV, Bodey GP, Kontoyiannis DPCancerPerspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer. 2005 Mar 15; 103(6):1103-13.Cancer2005-03-15T00:00:002005Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.21617635Terzis ID, Papamichail C, Psaltopoulou T, Georgiopoulos GA, Lipsou N, Chatzidou S, Kontoyiannis D, Kollias G, Iacovidou N, Zakopoulos N, Alevizaki M, Stamatelopoulos KSObesity (Silver Spring, Md.)Long-Term BMI changes since adolescence and markers of early and advanced subclinical atherosclerosis. Obesity (Silver Spring). 2012 Feb; 20(2):414-20.Obesity (Silver Spring)2011-05-26T00:00:002011Long-Term BMI changes since adolescence and markers of early and advanced subclinical atherosclerosis.21622653Kontoyiannis DP, Lewis REBloodHow I treat mucormycosis. Blood. 2011 Aug 04; 118(5):1216-24.Blood2011-05-26T00:00:002011How I treat mucormycosis.21659609Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad IThe oncologistOutcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist. 2011; 16(7):1049-60.Oncologist2011-06-09T00:00:002011Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles.21673574Marom EM, Kontoyiannis DPCurrent opinion in infectious diseasesImaging studies for diagnosing invasive fungal pneumonia in immunocompromised patients. Curr Opin Infect Dis. 2011 Aug; 24(4):309-14.Curr Opin Infect Dis2011-08-01T00:00:002011Imaging studies for diagnosing invasive fungal pneumonia in immunocompromised patients.Authorship 3744631815776383Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad IIThe Journal of infectious diseasesZygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005 Apr 15; 191(8):1350-60.J Infect Dis2005-03-16T00:00:002005Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.15801950Lionakis MS, Kontoyiannis DPBritish journal of haematologySinus zygomycosis in a patient receiving voriconazole prophylaxis. Br J Haematol. 2005 Apr; 129(1):2.Br J Haematol2005-04-01T00:00:002005Sinus zygomycosis in a patient receiving voriconazole prophylaxis.15878437Lionakis MS, Lewis RE, Torres HA, Albert ND, Raad II, Kontoyiannis DPDiagnostic microbiology and infectious diseaseIncreased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis. 2005 May; 52(1):15-20.Diagn Microbiol Infect Dis2005-05-01T00:00:002005Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.15937764Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPredictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis. 2005 Jul 01; 41(1):60-6.Clin Infect Dis2005-05-24T00:00:002005Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.22247446Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaEarly clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012 Feb; 54 Suppl 1:S55-60.Clin Infect Dis2012-02-01T00:00:002012Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis).22314534Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, Wiener-Well Y, Weinberger M, Zimhony O, Chowers M, Weber G, Potasman I, Chazan B, Kassis I, Shalit I, Block C, Keller N, Kontoyiannis DP, Giladi M, Israeli Candidemia Study GroupAntimicrobial agents and chemotherapyAntibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother. 2012 May; 56(5):2518-23.Antimicrob Agents Chemother2012-02-06T00:00:002012Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.22435877Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, Ibrahim AS, Brass EPMedical mycologyRisk factors for mortality in patients with mucormycosis. Med Mycol. 2012 Aug; 50(6):611-8.Med Mycol2012-03-21T00:00:002012Risk factors for mortality in patients with mucormycosis.16088459Lionakis MS, Kontoyiannis DPSeminars in respiratory and critical care medicineFusarium infections in critically ill patients. Semin Respir Crit Care Med. 2004 Apr; 25(2):159-69.Semin Respir Crit Care Med2004-04-01T00:00:002004Fusarium infections in critically ill patients.16990037Chamilos G, Lewis RE, Kontoyiannis DPFungal genetics and biology : FG & BMultidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: A hypothesis. Fungal Genet Biol. 2007 Feb; 44(2):88-92.Fungal Genet Biol2006-09-20T00:00:002006Multidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: A hypothesis.16164392Lionakis MS, Lewis RE, Chamilos G, Kontoyiannis DPPharmacotherapyAspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy. Pharmacotherapy. 2005 Sep; 25(9):1174-80.Pharmacotherapy2005-09-01T00:00:002005Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy.22680976Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PGMedical mycologyAntifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Med Mycol. 2013 Feb; 51(2):128-35.Med Mycol2012-06-11T00:00:002012Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.17182343Chamilos G, Lionakis MS, Lewis RE, Kontoyiannis DPThe Lancet. Infectious diseasesRole of mini-host models in the study of medically important fungi. Lancet Infect Dis. 2007 Jan; 7(1):42-55.Lancet Infect Dis2007-01-01T00:00:002007Role of mini-host models in the study of medically important fungi.16333108Lewis RE, Wiederhold NP, Lionakis MS, Prince RA, Kontoyiannis DPJournal of clinical microbiologyFrequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. J Clin Microbiol. 2005 Dec; 43(12):6120-2.J Clin Microbiol2005-12-01T00:00:002005Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center.17210526Kontoyiannis DP, Chamilos G, Hassan SA, Lewis RE, Albert ND, Tarrand JJAmerican journal of clinical pathologyIncreased culture recovery of Zygomycetes under physiologic temperature conditions. Am J Clin Pathol. 2007 Feb; 127(2):208-12.Am J Clin Pathol2007-02-01T00:00:002007Increased culture recovery of Zygomycetes under physiologic temperature conditions.16387749Lewis RE, Wiederhold NP, Prince RA, Kontoyiannis DPThe Journal of antimicrobial chemotherapyIn vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin. J Antimicrob Chemother. 2006 Feb; 57(2):288-93.J Antimicrob Chemother2005-12-30T00:00:002005In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin.23170870Georgiadou SP, Tarrand J, Sipsas NV, Kontoyiannis DPMycosesCandiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker? Mycoses. 2013 May; 56(3):311-4.Mycoses2012-11-22T00:00:002012Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker?23242544Lewis RE, Ben-Ami R, Best L, Albert N, Walsh TJ, Kontoyiannis DPThe Journal of infectious diseasesTacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis. J Infect Dis. 2013 Mar 01; 207(5):834-41.J Infect Dis2012-12-13T00:00:002012Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis.16511748van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPosaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006 Apr 01; 42(7):e61-5.Clin Infect Dis2006-02-21T00:00:002006Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.16518764Chamilos G, Lionakis MS, Lewis RE, Lopez-Ribot JL, Saville SP, Albert ND, Halder G, Kontoyiannis DPThe Journal of infectious diseasesDrosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis. 2006 Apr 01; 193(7):1014-22.J Infect Dis2006-02-28T00:00:002006Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.23547139Diaz L, Kontoyiannis DP, Panesso D, Albert ND, Singh KV, Tran TT, Munita JM, Murray BE, Arias CAThe Journal of infectious diseasesDissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus. J Infect Dis. 2013 Jul; 208(1):83-91.J Infect Dis2013-04-01T00:00:002013Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus.23696824Shirazi F, Kontoyiannis DPPloS oneMitochondrial respiratory pathways inhibition in Rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis. PLoS One. 2013; 8(5):e63393.PLoS One2013-05-17T00:00:002013Mitochondrial respiratory pathways inhibition in Rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis.23736876Granwehr BP, Kontoyiannis DPCurrent opinion in oncologyThe impact of infectious diseases consultation on oncology practice. Curr Opin Oncol. 2013 Jul; 25(4):353-9.Curr Opin Oncol2013-07-01T00:00:002013The impact of infectious diseases consultation on oncology practice.17510263Wise MG, Healy M, Reece K, Smith R, Walton D, Dutch W, Renwick A, Huong J, Young S, Tarrand J, Kontoyiannis DPJournal of medical microbiologySpecies identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCR. J Med Microbiol. 2007 Jun; 56(Pt 6):778-787.J Med Microbiol2007-06-01T00:00:002007Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCR.16757415Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Raad II, Kontoyiannis DPHaematologicaInvasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006 Jul; 91(7):986-9.Haematologica2006-06-01T00:00:002006Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).16984870Kontoyiannis DP, Lewis REInfectious disease clinics of North AmericaInvasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006 Sep; 20(3):581-607, vi.Infect Dis Clin North Am2006-09-01T00:00:002006Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management.17984233Quezada G, Koshkina NV, Zweidler-McKay P, Zhou Z, Kontoyiannis DP, Kleinerman ESAntimicrobial agents and chemotherapyIntranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis. Antimicrob Agents Chemother. 2008 Feb; 52(2):716-8.Antimicrob Agents Chemother2007-11-05T00:00:002007Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.18035197Chamilos G, Luna M, Lewis RE, Chemaly R, Raad II, Kontoyiannis DPClinical therapeuticsEffects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Clin Ther. 2007 Sep; 29(9):1980-6.Clin Ther2007-09-01T00:00:002007Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.18041885Chou LS, Lewis RE, Ippoliti C, Champlin RE, Kontoyiannis DPPharmacotherapyCaspofungin as primary antifungal prophylaxis in stem cell transplant recipients. Pharmacotherapy. 2007 Dec; 27(12):1644-50.Pharmacotherapy2007-12-01T00:00:002007Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.18070977Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh NAntimicrobial agents and chemotherapyCalcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 2008 Feb; 52(2):735-8.Antimicrob Agents Chemother2007-12-10T00:00:002007Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis.18166808Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad IIHaematologicaHuman herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica. 2008 Jan; 93(1):157-8.Haematologica2008-01-01T00:00:002008Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection.17366455Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaDecrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis. Clin Infect Dis. 2007 Apr 15; 44(8):1089-90.Clin Infect Dis2007-03-02T00:00:002007Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis.18177225Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF, Infectious Diseases Society of AmericaClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaTreatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008 Feb 01; 46(3):327-60.Clin Infect Dis2008-02-01T00:00:002008Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.18190268Lamaris GA, Chamilos G, Lewis RE, Kontoyiannis DPThe Journal of infectious diseasesVirulence studies of Scedosporium and Fusarium species in Drosophila melanogaster. J Infect Dis. 2007 Dec 15; 196(12):1860-4.J Infect Dis2007-12-15T00:00:002007Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.18199036Spikes S, Xu R, Nguyen CK, Chamilos G, Kontoyiannis DP, Jacobson RH, Ejzykowicz DE, Chiang LY, Filler SG, May GSThe Journal of infectious diseasesGliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence. J Infect Dis. 2008 Feb 01; 197(3):479-86.J Infect Dis2008-02-01T00:00:002008Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence.18241628Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DPMayo Clinic proceedingsFungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc. 2008 Feb; 83(2):181-94.Mayo Clin Proc2008-02-01T00:00:002008Fungal infections complicating tumor necrosis factor alpha blockade therapy.18297544Chamilos G, Macapinlac HA, Kontoyiannis DPMedical mycologyThe use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol. 2008 Feb; 46(1):23-9.Med Mycol2008-02-01T00:00:002008The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections.18492913Marom EM, Holmes AM, Bruzzi JF, Truong MT, O'Sullivan PJ, Kontoyiannis DPAJR. American journal of roentgenologyImaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol. 2008 Jun; 190(6):1605-9.AJR Am J Roentgenol2008-06-01T00:00:002008Imaging of pulmonary fusariosis in patients with hematologic malignancies.18033614Qiao J, Kontoyiannis DP, Wan Z, Li R, Liu WMedical mycologyAntifungal activity of statins against Aspergillus species. Med Mycol. 2007 Nov; 45(7):589-93.Med Mycol2007-11-01T00:00:002007Antifungal activity of statins against Aspergillus species.18500936Lamaris GA, Lewis RE, Chamilos G, May GS, Safdar A, Walsh TJ, Raad II, Kontoyiannis DPThe Journal of infectious diseasesCaspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis. 2008 Jul 15; 198(2):186-92.J Infect Dis2008-07-15T00:00:002008Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.18070682Mays SR, Kunishige JH, Truong E, Kontoyiannis DP, Hymes SRSeminars in cutaneous medicine and surgeryApproach to the morbilliform eruption in the hematopoietic transplant patient. Semin Cutan Med Surg. 2007 Sep; 26(3):155-62.Semin Cutan Med Surg2007-09-01T00:00:002007Approach to the morbilliform eruption in the hematopoietic transplant patient.18520324Jacobson KL, Miceli MH, Tarrand JJ, Kontoyiannis DPMedicineLegionella pneumonia in cancer patients. Medicine (Baltimore). 2008 May; 87(3):152-159.Medicine (Baltimore)2008-05-01T00:00:002008Legionella pneumonia in cancer patients.18558877Walsh TJ, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaEditorial commentary: what is the role of combination therapy in management of zygomycosis? Clin Infect Dis. 2008 Aug 01; 47(3):372-4.Clin Infect Dis2008-08-01T00:00:002008Editorial commentary: what is the role of combination therapy in management of zygomycosis?18305201Lewis RE, Albert ND, Kontoyiannis DPThe Journal of antimicrobial chemotherapyComparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. J Antimicrob Chemother. 2008 May; 61(5):1140-4.J Antimicrob Chemother2008-02-27T00:00:002008Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis.18654923Lewis RE, Kontoyiannis DPMedical mycologyInvasive aspergillosis in glucocorticoid-treated patients. Med Mycol. 2009; 47 Suppl 1:S271-81.Med Mycol2008-07-24T00:00:002008Invasive aspergillosis in glucocorticoid-treated patients.18694335Ibrahim AS, Gebremariam T, Liu M, Chamilos G, Kontoyiannis D, Mink R, Kwon-Chung KJ, Fu Y, Skory CD, Edwards JE, Spellberg BThe Journal of infectious diseasesBacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis. J Infect Dis. 2008 Oct 01; 198(7):1083-90.J Infect Dis2008-10-01T00:00:002008Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis.18783924Raad II, Hachem RY, Hanna HA, Fang X, Jiang Y, Dvorak T, Sherertz RJ, Kontoyiannis DPInternational journal of antimicrobial agentsRole of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents. 2008 Dec; 32(6):515-8.Int J Antimicrob Agents2008-09-09T00:00:002008Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm.18725439Lewis RE, Albert ND, Kontoyiannis DPAntimicrobial agents and chemotherapyEfficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2008 Nov; 52(11):4178-80.Antimicrob Agents Chemother2008-08-25T00:00:002008Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis.18775205Lionakis MS, Samonis G, Kontoyiannis DPMayo Clinic proceedingsEndocrine and metabolic manifestations of invasive fungal infections and systemic antifungal treatment. Mayo Clin Proc. 2008 Sep; 83(9):1046-60.Mayo Clin Proc2008-09-01T00:00:002008Endocrine and metabolic manifestations of invasive fungal infections and systemic antifungal treatment.18794386Garcia-Effron G, Kontoyiannis DP, Lewis RE, Perlin DSAntimicrobial agents and chemotherapyCaspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrob Agents Chemother. 2008 Nov; 52(11):4181-3.Antimicrob Agents Chemother2008-09-15T00:00:002008Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.19251404Sipsas NV, Lewis RE, Raad II, Kontoyiannis DPInternational journal of antimicrobial agentsMonotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study. Int J Antimicrob Agents. 2009 Jul; 34(1):95-8.Int J Antimicrob Agents2009-02-28T00:00:002009Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study.19491674Ben-Ami R, Lewis RE, Kontoyiannis DPCurrent opinion in infectious diseasesInvasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges. Curr Opin Infect Dis. 2009 Aug; 22(4):376-84.Curr Opin Infect Dis2009-08-01T00:00:002009Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges.19576639Ben-Ami R, Luna M, Lewis RE, Walsh TJ, Kontoyiannis DPThe Journal of infectionA clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response. J Infect. 2009 Aug; 59(2):134-8.J Infect2009-06-11T00:00:002009A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response.19635439Nedel WL, Kontoyiannis DP, Pasqualotto ACRevista iberoamericana de micologiaAspergillosis in patients treated with monoclonal antibodies. Rev Iberoam Micol. 2009 Sep 30; 26(3):175-83.Rev Iberoam Micol2009-07-18T00:00:002009Aspergillosis in patients treated with monoclonal antibodies.19642052Ben-Ami R, Lamaris GA, Lewis RE, Kontoyiannis DPMedical mycologyInterstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosis. Med Mycol. 2010 Mar; 48(2):310-7.Med Mycol2010-03-01T00:00:002010Interstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosis.19435437Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim ASClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaRecent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009 Jun 15; 48(12):1743-51.Clin Infect Dis2009-06-15T00:00:002009Recent advances in the management of mucormycosis: from bench to bedside.19463063Chamilos G, Nobile CJ, Bruno VM, Lewis RE, Mitchell AP, Kontoyiannis DPThe Journal of infectious diseasesCandida albicans Cas5, a regulator of cell wall integrity, is required for virulence in murine and toll mutant fly models. J Infect Dis. 2009 Jul 01; 200(1):152-7.J Infect Dis2009-07-01T00:00:002009Candida albicans Cas5, a regulator of cell wall integrity, is required for virulence in murine and toll mutant fly models.19692558Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Balajee SA, Pappas PG, Moser SAJournal of clinical microbiologyPatterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009 Oct; 47(10):3271-5.J Clin Microbiol2009-08-19T00:00:002009Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.19551882Granger JM, Kontoyiannis DPCancerEtiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. Cancer. 2009 Sep 01; 115(17):3919-23.Cancer2009-09-01T00:00:002009Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study.20173128Tan CH, Kontoyiannis DP, Viswanathan C, Iyer RBAJR. American journal of roentgenologyTuberculosis: a benign impostor. AJR Am J Roentgenol. 2010 Mar; 194(3):555-61.AJR Am J Roentgenol2010-03-01T00:00:002010Tuberculosis: a benign impostor.20047485Leventakos K, Lewis RE, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaFungal infections in leukemia patients: how do we prevent and treat them? Clin Infect Dis. 2010 Feb 01; 50(3):405-15.Clin Infect Dis2010-02-01T00:00:002010Fungal infections in leukemia patients: how do we prevent and treat them?20618330Ben-Ami R, Lewis RE, Kontoyiannis DPBritish journal of haematologyEnemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. Br J Haematol. 2010 Aug; 150(4):406-17.Br J Haematol2010-07-07T00:00:002010Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection.20370364Chamilos G, Bignell EM, Schrettl M, Lewis RE, Leventakos K, May GS, Haas H, Kontoyiannis DPMedical mycologyExploring the concordance of Aspergillus fumigatus pathogenicity in mice and Toll-deficient flies. Med Mycol. 2010 May; 48(3):506-10.Med Mycol2010-05-01T00:00:002010Exploring the concordance of Aspergillus fumigatus pathogenicity in mice and Toll-deficient flies.21028945Ben-Ami R, Lewis RE, Kontoyiannis DPMedical mycologyIn vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods. Med Mycol. 2011 Apr; 49(3):285-8.Med Mycol2010-10-28T00:00:002010In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods.21042306Kontoyiannis DPBone marrow transplantationAntifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success. Bone Marrow Transplant. 2011 Feb; 46(2):165-73.Bone Marrow Transplant2010-11-01T00:00:002010Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.20482268Cahuayme-Zuniga L, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaIs it safe to proceed with stem cell transplant in cancer patients treated for cryptococcal infection? A focus on recent IDSA cryptococcal guidelines. Clin Infect Dis. 2010 Jun 15; 50(12):1687-9.Clin Infect Dis2010-06-15T00:00:002010Is it safe to proceed with stem cell transplant in cancer patients treated for cryptococcal infection? A focus on recent IDSA cryptococcal guidelines.21178435Ben-Ami R, Varga V, Lewis RE, May GS, Nierman WC, Kontoyiannis DPVirulenceCharacterization of a 5-azacytidine-induced developmental Aspergillus fumigatus variant. Virulence. 2010 May-Jun; 1(3):164-73.Virulence2010-05-01T00:00:002010Characterization of a 5-azacytidine-induced developmental Aspergillus fumigatus variant.21178494Lionakis MS, Kontoyiannis DPVirulenceThe growing promise of Toll-deficient Drosophila melanogaster as a model for studying Aspergillus pathogenesis and treatment. Virulence. 2010 Nov-Dec; 1(6):488-99.Virulence2010-11-01T00:00:002010The growing promise of Toll-deficient Drosophila melanogaster as a model for studying Aspergillus pathogenesis and treatment.21178507Evans SE, Leventakos K, Ben-Ami R, You D, Thakkar SG, Lewis RE, Kontoyiannis DPVirulenceToll-deficient Drosophila are resistant to infection by Pneumocystis spp.: additional evidence of specificity to mammalian hosts. Virulence. 2010 Nov-Dec; 1(6):523-5.Virulence2010-11-01T00:00:002010Toll-deficient Drosophila are resistant to infection by Pneumocystis spp.: additional evidence of specificity to mammalian hosts.20616663Safdar A, Ma J, Saliba F, Dupont B, Wingard JR, Hachem RY, Mattiuzzi GN, Chandrasekar PH, Kontoyiannis DP, Rolston KV, Walsh TJ, Champlin RE, Raad IIMedicineDrug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis. Medicine (Baltimore). 2010 Jul; 89(4):236-244.Medicine (Baltimore)2010-07-01T00:00:002010Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis.21470115Chamilos G, Samonis G, Kontoyiannis DPCurrent pharmaceutical designDrosophila melanogaster as a model host for the study of microbial pathogenicity and the discovery of novel antimicrobial compounds. Curr Pharm Des. 2011; 17(13):1246-53.Curr Pharm Des2011-01-01T00:00:002011Drosophila melanogaster as a model host for the study of microbial pathogenicity and the discovery of novel antimicrobial compounds.21537029Lewis RE, Leventakos K, Liao G, Kontoyiannis DPAntimicrobial agents and chemotherapyEfficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis. Antimicrob Agents Chemother. 2011 Jul; 55(7):3584-7.Antimicrob Agents Chemother2011-05-02T00:00:002011Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis.21666457Mulanovich VE, Kontoyiannis DPCurrent opinion in infectious diseasesFungal pneumonia in patients with hematologic malignancies: current approach and management. Curr Opin Infect Dis. 2011 Aug; 24(4):323-32.Curr Opin Infect Dis2011-08-01T00:00:002011Fungal pneumonia in patients with hematologic malignancies: current approach and management.21670187Lockhart SR, Zimbeck AJ, Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Pappas PG, Chiller TAntimicrobial agents and chemotherapyIn vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrob Agents Chemother. 2011 Aug; 55(8):3944-6.Antimicrob Agents Chemother2011-06-13T00:00:002011In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.21888790Al Akhrass F, Hachem R, Mohamed JA, Tarrand J, Kontoyiannis DP, Chandra J, Ghannoum M, Haydoura S, Chaftari AM, Raad IEmerging infectious diseasesCentral venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis. 2011 Sep; 17(9):1651-8.Emerg Infect Dis2011-09-01T00:00:002011Central venous catheter-associated Nocardia bacteremia in cancer patients.20886035Chamilos G, Ganguly D, Lande R, Gregorio J, Meller S, Goldman WE, Gilliet M, Kontoyiannis DPPloS oneGeneration of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses. PLoS One. 2010 Sep 23; 5(9):e12955.PLoS One2010-09-23T00:00:002010Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses.21962326Perfect JR, Pfaller MA, Ostrosky-Zeichner L, Kontoyiannis DPThe American journal of medicineInvasive mycoses: evolving challenges and opportunities in antifungal therapy (multimedia activity). Am J Med. 2011 Oct; 124(10):S2-3.Am J Med2011-10-01T00:00:002011Invasive mycoses: evolving challenges and opportunities in antifungal therapy (multimedia activity).22101079Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DPThe Journal of infectionRare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J Infect. 2012 Jan; 64(1):68-75.J Infect2011-11-11T00:00:002011Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.22167397Hamilos G, Samonis G, Kontoyiannis DPSeminars in respiratory and critical care medicinePulmonary mucormycosis. Semin Respir Crit Care Med. 2011 Dec; 32(6):693-702.Semin Respir Crit Care Med2011-12-13T00:00:002011Pulmonary mucormycosis.22173185Kontoyiannis DPRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de QuimioterapiaA clinical approach to assess treatment for presumed and documented invasive mold infections in patients with hematologic malignancies: focus on Spanish Society of Chemotherapy Guidelines. Rev Esp Quimioter. 2011 Dec; 24(4):173-4.Rev Esp Quimioter2011-12-01T00:00:002011A clinical approach to assess treatment for presumed and documented invasive mold infections in patients with hematologic malignancies: focus on Spanish Society of Chemotherapy Guidelines.22247440Walsh TJ, Bloom BE, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaMeeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on Mucormycosis. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S1-4.Clin Infect Dis2012-02-01T00:00:002012Meeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on Mucormycosis.22247442Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaEpidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S23-34.Clin Infect Dis2012-02-01T00:00:002012Epidemiology and clinical manifestations of mucormycosis.22247447Roilides E, Kontoyiannis DP, Walsh TJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaHost defenses against zygomycetes. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S61-6.Clin Infect Dis2012-02-01T00:00:002012Host defenses against zygomycetes.22247449Spellberg B, Ibrahim A, Roilides E, Lewis RE, Lortholary O, Petrikkos G, Kontoyiannis DP, Walsh TJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaCombination therapy for mucormycosis: why, what, and how? Clin Infect Dis. 2012 Feb; 54 Suppl 1:S73-8.Clin Infect Dis2012-02-01T00:00:002012Combination therapy for mucormycosis: why, what, and how?21077735Al Akhrass F, Debiane L, Abdallah L, Best L, Mulanovich V, Rolston K, Kontoyiannis DPMedical mycologyPalatal mucormycosis in patients with hematologic malignancy and stem cell transplantation. Med Mycol. 2011 May; 49(4):400-5.Med Mycol2010-11-15T00:00:002010Palatal mucormycosis in patients with hematologic malignancy and stem cell transplantation.22328395Lionakis MS, Kontoyiannis DPMethods in molecular biology (Clifton, N.J.)Drosophila melanogaster as a model organism for invasive aspergillosis. Methods Mol Biol. 2012; 845:455-68.Methods Mol Biol2012-01-01T00:00:002012Drosophila melanogaster as a model organism for invasive aspergillosis.22378911Tarrand JJ, LaSala PR, Han XY, Rolston KV, Kontoyiannis DPJournal of clinical microbiologyDimethyl sulfoxide enhances effectiveness of skin antiseptics and reduces contamination rates of blood cultures. J Clin Microbiol. 2012 May; 50(5):1552-7.J Clin Microbiol2012-02-29T00:00:002012Dimethyl sulfoxide enhances effectiveness of skin antiseptics and reduces contamination rates of blood cultures.21191800Pongas G, Hamilos G, Rolston KV, Kontoyiannis DPSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerFormal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998-2008): diverse and impactful. Support Care Cancer. 2012 Feb; 20(2):261-5.Support Care Cancer2010-12-30T00:00:002010Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998-2008): diverse and impactful.22459004Torres HA, Nevah MI, Barnett BJ, Mahale P, Kontoyiannis DP, Hassan MM, Raad IIJournal of clinical virology : the official publication of the Pan American Society for Clinical VirologyHepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study. J Clin Virol. 2012 Jul; 54(3):218-22.J Clin Virol2012-03-28T00:00:002012Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study.21236398Person AK, Kontoyiannis DP, Alexander BDHematology/oncology clinics of North AmericaFungal infections in transplant and oncology patients. Hematol Oncol Clin North Am. 2011 Feb; 25(1):193-213.Hematol Oncol Clin North Am2011-02-01T00:00:002011Fungal infections in transplant and oncology patients.22546902Muhammed M, Feldmesser M, Shubitz LF, Lionakis MS, Sil A, Wang Y, Glavis-Bloom J, Lewis RE, Galgiani JN, Casadevall A, Kontoyiannis DP, Mylonakis EVirulenceMouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus. Virulence. 2012 May 01; 3(3):329-38.Virulence2012-05-01T00:00:002012Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus.21543881Kontoyiannis DPVirulenceDeferasirox lacks in vitro activity against Fusarium and Scedosporium species and black molds. Virulence. 2011 May-Jun; 2(3):257-8.Virulence2011-05-01T00:00:002011Deferasirox lacks in vitro activity against Fusarium and Scedosporium species and black molds.22911646Gamaletsou MN, Kontoyiannis DP, Sipsas NV, Moriyama B, Alexander E, Roilides E, Brause B, Walsh TJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaCandida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011). Clin Infect Dis. 2012 Nov 15; 55(10):1338-51.Clin Infect Dis2012-08-21T00:00:002012Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011).22975207Gamaletsou MN, Sipsas NV, Kontoyiannis DP, Tsiakalos A, Kontos AN, Stefanou I, Kordossis TDiagnostic microbiology and infectious diseaseSuccessful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-?. Diagn Microbiol Infect Dis. 2012 Dec; 74(4):409-11.Diagn Microbiol Infect Dis2012-09-10T00:00:002012Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-?.21701255Chen SC, Lewis RE, Kontoyiannis DPVirulenceDirect effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species. Virulence. 2011 Jul-Aug; 2(4):280-95.Virulence2011-07-01T00:00:002011Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.21791665Ben-Ami R, Garcia-Effron G, Lewis RE, Gamarra S, Leventakos K, Perlin DS, Kontoyiannis DPThe Journal of infectious diseasesFitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance. J Infect Dis. 2011 Aug 15; 204(4):626-35.J Infect Dis2011-08-15T00:00:002011Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.23345420McGrath DM, Barbu EM, Driessen WH, Lasco TM, Tarrand JJ, Okhuysen PC, Kontoyiannis DP, Sidman RL, Pasqualini R, Arap WProceedings of the National Academy of Sciences of the United States of AmericaMechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. Proc Natl Acad Sci U S A. 2013 Feb 26; 110(9):3477-82.Proc Natl Acad Sci U S A2013-01-23T00:00:002013Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic.21930861Kontoyiannis DPAnnals of internal medicineThe power of a legend. Ann Intern Med. 2011 Sep 20; 155(6):400.Ann Intern Med2011-09-20T00:00:002011The power of a legend.21937481Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EPThe Journal of antimicrobial chemotherapyThe Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother. 2012 Mar; 67(3):715-22.J Antimicrob Chemother2011-09-20T00:00:002011The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.22000355Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito JI, Kauffman CA, Lyon GM, Marr KA, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wingard JR, Walsh TJ, Kontoyiannis DPEmerging infectious diseasesInvasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis. 2011 Oct; 17(10):1855-64.Emerg Infect Dis2011-10-01T00:00:002011Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.28245856Galloway-Pe?a JR, Smith DP, Sahasrabhojane P, Wadsworth WD, Fellman BM, Ajami NJ, Shpall EJ, Daver N, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SAGenome medicineCharacterization of oral and gut microbiome temporal variability in hospitalized cancer patients. Genome Med. 2017 02 28; 9(1):21.Genome Med2017-02-28T00:00:002017Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.23546567Kontoyiannis DPAnnals of internal medicinePreventing fungal disease in chronically immunosuppressed outpatients: time for action? Ann Intern Med. 2013 Apr 02; 158(7):555-6.Ann Intern Med2013-04-02T00:00:002013Preventing fungal disease in chronically immunosuppressed outpatients: time for action?22247448Lewis RE, Lortholary O, Spellberg B, Roilides E, Kontoyiannis DP, Walsh TJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaHow does antifungal pharmacology differ for mucormycosis versus aspergillosis? Clin Infect Dis. 2012 Feb; 54 Suppl 1:S67-72.Clin Infect Dis2012-02-01T00:00:002012How does antifungal pharmacology differ for mucormycosis versus aspergillosis?22286697Ben-Ami R, Kontoyiannis DPVirulenceResistance to echinocandins comes at a cost: the impact of FKS1 hotspot mutations on Candida albicans fitness and virulence. Virulence. 2012 Jan-Feb; 3(1):95-7.Virulence2012-01-01T00:00:002012Resistance to echinocandins comes at a cost: the impact of FKS1 hotspot mutations on Candida albicans fitness and virulence.22328405Ben-Ami R, Kontoyiannis DPMethods in molecular biology (Clifton, N.J.)A nonlethal murine cutaneous model of invasive aspergillosis. Methods Mol Biol. 2012; 845:569-82.Methods Mol Biol2012-01-01T00:00:002012A nonlethal murine cutaneous model of invasive aspergillosis.22337064Sipsas NV, Kontoyiannis DPInternational journal of antimicrobial agentsInvasive fungal infections in patients with cancer in the Intensive Care Unit. Int J Antimicrob Agents. 2012 Jun; 39(6):464-71.Int J Antimicrob Agents2012-02-14T00:00:002012Invasive fungal infections in patients with cancer in the Intensive Care Unit.Authorship 841501Authorship 842026Authorship 842050Authorship 842165Authorship 842240Authorship 842417Authorship 842942Authorship 843261Authorship 843327Authorship 843373Authorship 843585Authorship 843676Authorship 843866Authorship 844048Authorship 844332Authorship 844362Authorship 844572Authorship 845206Authorship 847538Authorship 847700Authorship 847943Authorship 848500Authorship 848774Authorship 849303Authorship 849345Authorship 849430Authorship 850093Authorship 850168Authorship 850254Authorship 850397Authorship 850543Authorship 851103Authorship 851217Authorship 851361Authorship 852226Authorship 852454Authorship 852456Authorship 853851Authorship 854078Authorship 854200Authorship 855228Authorship 856360Authorship 858425Authorship 858598Authorship 859240Authorship 859899Authorship 859949Authorship 860045Authorship 860188Authorship 860699Authorship 86099022518146Hamilos G, Samonis G, Kontoyiannis DPInternational journal of microbiologyRecent Advances in the Use of Drosophila melanogaster as a Model to Study Immunopathogenesis of Medically Important Filamentous Fungi. Int J Microbiol. 2012; 2012:583792.Int J Microbiol2012-02-19T00:00:002012Recent Advances in the Use of Drosophila melanogaster as a Model to Study Immunopathogenesis of Medically Important Filamentous Fungi.Authorship 862019Authorship 862230Authorship 862425Authorship 862626Authorship 862681Authorship 863293Authorship 863564Authorship 863928Authorship 864027Authorship 864330Authorship 864391Authorship 864392Authorship 864573Authorship 865383Authorship 866191Authorship 867139Authorship 867179Authorship 867903Pediatric Infectious Disease JournalUse of ceftolozane/tazobactam in the treatment of multidrug-resistant pseudomonas aeruginosa bloodstream infection in a pediatric leukemia patient. Pediatric Infectious Disease Journal. 35:1040-1042.Use of ceftolozane/tazobactam in the treatment of multidrug-resistant pseudomonas aeruginosa bloodstream infection in a pediatric leukemia patientPathogenesis of Invasive Pulmonary Aspergillosis. 345-379.Pathogenesis of Invasive Pulmonary AspergillosisONCOLOGY (United States)The evolving landscape of gastrointestinal infections in neutropenic patients. ONCOLOGY (United States). 29.The evolving landscape of gastrointestinal infections in neutropenic patientsBiology of Blood and Marrow TransplantationThe Burden of Bacterial and Viral Infections in Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 15:128-133.The Burden of Bacterial and Viral Infections in Hematopoietic Stem Cell TransplantVirulenceGlucocorticosteroids do not impact directly growth rate and biomass of Rhizopus arrhizus (syn. R. oryzae) in vitro. Virulence. 6:441-443.Glucocorticosteroids do not impact directly growth rate and biomass of Rhizopus arrhizus (syn. R. oryzae) in vitroEmerging Infectious DiseasesUncommon Candida species fungemia among cancer patients, Houston, Texas, USA. Emerging Infectious Diseases. 21:1942-1950.Uncommon Candida species fungemia among cancer patients, Houston, Texas, USAAntimicrobial Agents and ChemotherapyEffect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae. Antimicrobial Agents and Chemotherapy. 59:7830-7832.Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzaeBloodInvasive aspergillosis (IA) in patients with leukemia and bone marrow transplant patients (PTS). Blood. 96.Invasive aspergillosis (IA) in patients with leukemia and bone marrow transplant patients (PTS)VirulenceInfections following allogeneic stem cell transplantation. Virulence. 7:898-900.Infections following allogeneic stem cell transplantationGastroenterology and HepatologyGastrointestinal mucormycosis. Gastroenterology and Hepatology. 5:661-662.Gastrointestinal mucormycosisPLoS OneBiofilm filtrates of pseudomonas aeruginosa strains isolated from cystic fibrosis patients inhibit preformed Aspergillus fumigatus biofilms via apoptosis. PLoS One. 11.Biofilm filtrates of pseudomonas aeruginosa strains isolated from cystic fibrosis patients inhibit preformed Aspergillus fumigatus biofilms via apoptosisMycetoma. 2005-2007.MycetomaMicrobeStudying Fungal Pathogenesis in Drosophila. Microbe. 5:291-296.Studying Fungal Pathogenesis in DrosophilaJournal of Invasive Fungal InfectionsA man with acute myeloid leukemia, fever, and hip pain. Journal of Invasive Fungal Infections. 3:15-17.A man with acute myeloid leukemia, fever, and hip painBloodPrimary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. Blood. 126:2790-2797.Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemiaClinical Infectious DiseasesExecutive summary. Clinical Infectious Diseases. 63:433-442.Executive summaryAgents of Mucormycosis and Entomophthoramycosis. 2909-2919.Agents of Mucormycosis and EntomophthoramycosisVirulenceIron starvation induces apoptosis in rhizopus oryzae in vitro. Virulence. 6:121-126.Iron starvation induces apoptosis in rhizopus oryzae in vitroClinical Microbiology and InfectionInitial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis. Clinical Microbiology and Infection. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosisCurrent Fungal Infection ReportsInvasive candidiasis in the neutropenic cancer patient. Current Fungal Infection Reports. 5:34-41.Invasive candidiasis in the neutropenic cancer patientClinical Infectious DiseasesPractice guidelines for the diagnosis and management of aspergillosis. Clinical Infectious Diseases. 63:e1-e60.Practice guidelines for the diagnosis and management of aspergillosisCurrent Fungal Infection ReportsImmunomodulating effects of antifungal therapy. Current Fungal Infection Reports. 3:243-250.Immunomodulating effects of antifungal therapyMedical MycologyDefining the diagnosis of invasive aspergillosis. Medical Mycology. 44:163-172.Defining the diagnosis of invasive aspergillosisMedicine (United States)Factors affecting patient outcome in primary cutaneous aspergillosis. Medicine (United States). 95.Factors affecting patient outcome in primary cutaneous aspergillosisAntimicrobial Agents and ChemotherapyEfficacy and tolerability of micafungin monotherapy for candidemia and deep-seated candidiasis in adults with cancer. Antimicrobial Agents and Chemotherapy. 58:3526-3529.Efficacy and tolerability of micafungin monotherapy for candidemia and deep-seated candidiasis in adults with cancerEuropean Journal of Clinical Microbiology and Infectious DiseasesErratum. European Journal of Clinical Microbiology and Infectious Diseases. 25:69.ErratumPLoS OneCorrelation between circulating fungal biomarkers and clinical outcome in invasive aspergillosis. PLoS One. 10.Correlation between circulating fungal biomarkers and clinical outcome in invasive aspergillosisInfections in MedicineEditorial comment. Infections in Medicine. 21:40.Editorial commentAntimicrobial Agents and ChemotherapyErratum. Antimicrobial Agents and Chemotherapy. 48:4072.ErratumJournal of Clinical InvestigationBicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis. Journal of Clinical Investigation. 126:2280-2294.Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosisMycosesMicafungin in haematology. Mycoses. 55:13-23.Micafungin in haematologyTuberculosis and Respiratory DiseasesCo-infection with influenza. Tuberculosis and Respiratory Diseases. 76:249.Co-infection with influenzaCurrent Opinion in Infectious DiseasesTreatment of mucormycosis in transplant patients. Current Opinion in Infectious Diseases. Treatment of mucormycosis in transplant patientsVirulenceMicafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates. Virulence. 6:385-394.Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolatesOpen Forum Infectious DiseasesCandida arthritis. Open Forum Infectious Diseases. 3.Candida arthritisDiagnostic Microbiology and Infectious DiseaseTime-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patients. Diagnostic Microbiology and Infectious Disease. Time-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patientsInfections in MedicinePrimary zygomycosis in cancer patients. Infections in Medicine. 22:42.Primary zygomycosis in cancer patientsMucormycosis. 1994-1997.MucormycosisPLoS OneImplementation of a pan-genomic approach to investigate holobiont-infecting microbe interaction. PLoS One. 10.Implementation of a pan-genomic approach to investigate holobiont-infecting microbe interactionJournal of InfectionFungal empyema thoracis in cancer patients. Journal of Infection. Fungal empyema thoracis in cancer patientsCell Host and MicrobeAspergillus Cell Wall Melanin Blocks LC3-Associated Phagocytosis to Promote Pathogenicity. Cell Host and Microbe. 19:79-90.Aspergillus Cell Wall Melanin Blocks LC3-Associated Phagocytosis to Promote PathogenicityAntimicrobial Agents and ChemotherapyAlbumin enhances caspofungin activity against Aspergillus species by facilitating drug delivery to germinating hyphae. Antimicrobial Agents and Chemotherapy. 60:1226-1233.Albumin enhances caspofungin activity against Aspergillus species by facilitating drug delivery to germinating hyphae22722245Lewis RE, Viale P, Kontoyiannis DPVirulenceThe potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. Virulence. 2012 Jul 01; 3(4):368-76.Virulence2012-06-22T00:00:002012The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida.American Journal of HematologyMixed angioinvasive exserohilum and scedosporium infection in a patient with AML. American Journal of Hematology. Mixed angioinvasive exserohilum and scedosporium infection in a patient with AMLAmerican Journal of TransplantationSymptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. American Journal of Transplantation. Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell RecipientsVirulenceVoriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection. Virulence. 2.Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infectionBone Marrow TransplantationDisseminated cryptococcal infection in allogeneic stem cell transplant patients. Bone Marrow Transplantation. 51:1301-1304.Disseminated cryptococcal infection in allogeneic stem cell transplant patientsDrosophila melanogaster as a versatile model for the discovery of drugs effective against human Microbe-induced infection and pathology. 300-309.Drosophila melanogaster as a versatile model for the discovery of drugs effective against human Microbe-induced infection and pathologyEmerging Infectious DiseasesInvasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerging Infectious Diseases. 17:1855-1864.Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006Clinical Infectious DiseasesErratum. Clinical Infectious Diseases. 35:110.ErratumClinical Infectious DiseasesReply to Hoenigl et al. Clinical Infectious Diseases. 51:254-255.Reply to Hoenigl et alTransplant Infectious DiseasePoor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transplant Infectious Disease. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipientsInfectious Diseases in Clinical PracticeRefractory cellulitis in a woman with chronic lymphedema. Infectious Diseases in Clinical Practice. 14:244-245.Refractory cellulitis in a woman with chronic lymphedemaVirulenceDirect effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species. Virulence. 2.Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus speciesJournal of Infectious DiseasesStatin Concentrations below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae. Journal of Infectious Diseases. 214:114-121.Statin Concentrations below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzaeNature CommunicationsPrevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance. Nature Communications. 7.Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistanceExpert Review of Anti-Infective TherapyAntifungal agents and liver toxicity. Expert Review of Anti-Infective Therapy. 14:765-776.Antifungal agents and liver toxicityClinical Infectious DiseasesErratum. Clinical Infectious Diseases. 39:1264.ErratumClinical Infectious DiseasesErratum. Clinical Infectious Diseases. 43:1376.ErratumInfectious Disease Clinics of North AmericaMucormycoses. Infectious Disease Clinics of North America. 30:143-163.MucormycosesVirulenceMouse models for the study of fungal pneumonia. Virulence. 3:15.Mouse models for the study of fungal pneumoniaJournal of Antimicrobial ChemotherapyIdentification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis. Journal of Antimicrobial Chemotherapy. 71:946-952.Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesisCentral European Journal of MedicineSubclinical tumor lysis-like syndrome during treatment of visceral leishmaniasis with low-dose intermittent liposomal amphotericin B. Central European Journal of Medicine. 7:305-309.Subclinical tumor lysis-like syndrome during treatment of visceral leishmaniasis with low-dose intermittent liposomal amphotericin BEnvironmental MicrobiologyRedundant synthesis of a conidial polyketide by two distinct secondary metabolite clusters in Aspergillus fumigatus. Environmental Microbiology. 18:246-259.Redundant synthesis of a conidial polyketide by two distinct secondary metabolite clusters in Aspergillus fumigatusDrugsMicafungin. Drugs. 64:983-984.MicafunginAntimicrobial Agents and ChemotherapyIdentification and characterization of a novel family of selective antifungal compounds (CANBEFs) that interfere with fungal protein synthesis. Antimicrobial Agents and Chemotherapy. 59:5631-5640.Identification and characterization of a novel family of selective antifungal compounds (CANBEFs) that interfere with fungal protein synthesisBMC Infectious DiseasesPrevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States. BMC Infectious Diseases. 16.Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United StatesHyalohyphomycoses (hyaline moulds). 281-304.Hyalohyphomycoses (hyaline moulds)Journal of the Pediatric Infectious Diseases SocietyInvasive mold infections in pediatric cancer patients reflect heterogeneity in etiology, presentation, and outcome. Journal of the Pediatric Infectious Diseases Society. 1:125-135.Invasive mold infections in pediatric cancer patients reflect heterogeneity in etiology, presentation, and outcomeJournal of Antimicrobial ChemotherapyPharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients. Journal of Antimicrobial Chemotherapy. 71:727-730.Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients22871500Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HAJournal of hepatologyAcute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012 Dec; 57(6):1177-85.J Hepatol2012-08-04T00:00:002012Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients.22927244Chamilos G, Gregorio J, Meller S, Lande R, Kontoyiannis DP, Modlin RL, Gilliet MBloodCytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood. 2012 Nov 01; 120(18):3699-707.Blood2012-08-27T00:00:002012Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37.23231710Georgiadou SP, Kontoyiannis DPAnnals of the New York Academy of SciencesThe impact of azole resistance on aspergillosis guidelines. Ann N Y Acad Sci. 2012 Dec; 1272:15-22.Ann N Y Acad Sci2012-12-01T00:00:002012The impact of azole resistance on aspergillosis guidelines.23232438Ben-Ami R, Watson CC, Lewis RE, Albert ND, Arias CA, Raad II, Kontoyiannis DPMicrobial pathogenesisDrosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment. Microb Pathog. 2013 Feb; 55:16-20.Microb Pathog2012-12-08T00:00:002012Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment.23638376Palmer JM, Bok JW, Lee S, Dagenais TRT, Andes DR, Kontoyiannis DP, Keller NPPeerJLoss of CclA, required for histone 3 lysine 4 methylation, decreases growth but increases secondary metabolite production in Aspergillus fumigatus. PeerJ. 2013; 1:e4.PeerJ2013-02-19T00:00:002013Loss of CclA, required for histone 3 lysine 4 methylation, decreases growth but increases secondary metabolite production in Aspergillus fumigatus.12099753Nannini EC, Keating M, Binstock P, Samonis G, Kontoyiannis DPThe Journal of infectionSuccessful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. J Infect. 2002 Apr; 44(3):201-3.J Infect2002-04-01T00:00:002002Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.27862740Abudayyeh A, Hamdi A, Abdelrahim M, Lin H, Page VD, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Oran B, Chemaly RF, Ahmed S, Abudayyeh I, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Rezvani KTransplant infectious disease : an official journal of the Transplantation SocietyPoor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2017 Feb; 19(1).Transpl Infect Dis2016-12-28T00:00:002016Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.12631595Mattiuzzi GN, Cortes JE, Talpaz M, Reuben J, Rios MB, Shan J, Kontoyiannis D, Giles FJ, Raad I, Verstovsek S, Ferrajoli A, Kantarjian HMClinical cancer research : an official journal of the American Association for Cancer ResearchDevelopment of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Clin Cancer Res. 2003 Mar; 9(3):976-80.Clin Cancer Res2003-03-01T00:00:002003Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate.12742315Torres HA, Rivero GA, Lewis RE, Hachem R, Raad II, Kontoyiannis DPDiagnostic microbiology and infectious diseaseAspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2003 May; 46(1):25-8.Diagn Microbiol Infect Dis2003-05-01T00:00:002003Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus.12817433Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS, Kontoyiannis DPAmerican journal of clinical pathologyDiagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol. 2003 Jun; 119(6):854-8.Am J Clin Pathol2003-06-01T00:00:002003Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination.14506038Lionakis MS, Lewis RE, Samonis G, Kontoyiannis DPAntimicrobial agents and chemotherapyPentamidine is active in vitro against Fusarium species. Antimicrob Agents Chemother. 2003 Oct; 47(10):3252-9.Antimicrob Agents Chemother2003-10-01T00:00:002003Pentamidine is active in vitro against Fusarium species.14522515Kontoyiannis DP, Lewis RE, Lionakis MS, Albert ND, May GS, Raad IIDiagnostic microbiology and infectious diseaseSequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity. Diagn Microbiol Infect Dis. 2003 Oct; 47(2):415-9.Diagn Microbiol Infect Dis2003-10-01T00:00:002003Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.14654323Lionakis MS, Kontoyiannis DPLancet (London, England)Glucocorticoids and invasive fungal infections. Lancet. 2003 Nov 29; 362(9398):1828-38.Lancet2003-11-29T00:00:002003Glucocorticoids and invasive fungal infections.15061210Kontoyiannis DP, Bodey GP, Hanna H, Hachem R, Boktour M, Girgaway E, Mardani M, Raad IILeukemia & lymphomaOutcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Leuk Lymphoma. 2004 Jan; 45(1):139-41.Leuk Lymphoma2004-01-01T00:00:002004Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery.15069017Couriel D, Saliba R, Hicks K, Ippoliti C, de Lima M, Hosing C, Khouri I, Andersson B, Gajewski J, Donato M, Anderlini P, Kontoyiannis DP, Cohen A, Martin T, Giralt S, Champlin RBloodTumor necrosis factor-alpha blockade for the treatment of acute GVHD. Blood. 2004 Aug 01; 104(3):649-54.Blood2004-04-06T00:00:002004Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.15215099Liu W, May GS, Lionakis MS, Lewis RE, Kontoyiannis DPAntimicrobial agents and chemotherapyExtra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus. Antimicrob Agents Chemother. 2004 Jul; 48(7):2490-6.Antimicrob Agents Chemother2004-07-01T00:00:002004Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus.15273155Lewis RE, Kontoyiannis DP, Kantoyiannis DPAntimicrobial agents and chemotherapyChallenges in designing animal studies to detect antagonism of polyene activity. Antimicrob Agents Chemother. 2004 Aug; 48(8):3211; author reply 3211-2.Antimicrob Agents Chemother2004-08-01T00:00:002004Challenges in designing animal studies to detect antagonism of polyene activity.15307028Steinbach WJ, Benjamin DK, Kontoyiannis DP, Perfect JR, Lutsar I, Marr KA, Lionakis MS, Torres HA, Jafri H, Walsh TJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaInfections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis. 2004 Jul 15; 39(2):192-8.Clin Infect Dis2004-06-28T00:00:002004Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.15370667Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad IIScandinavian journal of infectious diseasesTrichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004; 36(8):564-9.Scand J Infect Dis2004-01-01T00:00:002004Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome.15529309Safdar A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Lichtiger B, Freireich EJ, Raad IICancerImpact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer. 2004 Dec 15; 101(12):2859-65.Cancer2004-12-15T00:00:002004Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.15546954Stanzani M, Orciuolo E, Lewis R, Kontoyiannis DP, Martins SL, St John LS, Komanduri KVBloodAspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood. 2005 Mar 15; 105(6):2258-65.Blood2004-11-16T00:00:002004Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes.16080086Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaEpidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005 Sep 01; 41(5):634-53.Clin Infect Dis2005-07-29T00:00:002005Epidemiology and outcome of zygomycosis: a review of 929 reported cases.16143517Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RFEuropean journal of cancer (Oxford, England : 1990)Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005 Oct; 41(15):2268-79.Eur J Cancer2005-09-06T00:00:002005Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center.16239579Lionakis MS, Lahdenranta J, Sun J, Liu W, Lewis RE, Albert ND, Pasqualini R, Arap W, Kontoyiannis DPInfection and immunityDevelopment of a ligand-directed approach to study the pathogenesis of invasive aspergillosis. Infect Immun. 2005 Nov; 73(11):7747-58.Infect Immun2005-11-01T00:00:002005Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis.16304189Wiederhold NP, Kontoyiannis DP, Prince RA, Lewis REAntimicrobial agents and chemotherapyAttenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob Agents Chemother. 2005 Dec; 49(12):5146-8.Antimicrob Agents Chemother2005-12-01T00:00:002005Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways.16377673Chamilos G, Lewis RE, Kontoyiannis DPAntimicrobial agents and chemotherapyLovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother. 2006 Jan; 50(1):96-103.Antimicrob Agents Chemother2006-01-01T00:00:002006Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.16377700Lionakis MS, Chamilos G, Lewis RE, Wiederhold NP, Raad II, Samonis G, Kontoyiannis DPAntimicrobial agents and chemotherapyPentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis. Antimicrob Agents Chemother. 2006 Jan; 50(1):294-7.Antimicrob Agents Chemother2006-01-01T00:00:002006Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis.16436698Wiederhold NP, Tam VH, Chi J, Prince RA, Kontoyiannis DP, Lewis REAntimicrobial agents and chemotherapyPharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2006 Feb; 50(2):469-73.Antimicrob Agents Chemother2006-02-01T00:00:002006Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis.16436735Chamilos G, Lewis RE, Kontoyiannis DPAntimicrobial agents and chemotherapyInhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin. Antimicrob Agents Chemother. 2006 Feb; 50(2):744-7.Antimicrob Agents Chemother2006-02-01T00:00:002006Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin.16477215Singh N, Limaye AP, Forrest G, Safdar N, Mu?oz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain STransplantationCombination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation. 2006 Feb 15; 81(3):320-6.Transplantation2006-02-15T00:00:002006Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.16652316Sipsas NV, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaClinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies. Clin Infect Dis. 2006 Jun 01; 42(11):1584-91.Clin Infect Dis2006-04-24T00:00:002006Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies.16681815Garey KW, Neuhauser MM, Bearden DT, Cannon JP, Lewis RE, Gentry LO, Kontoyiannis DPMycosesEvaluation of antifungals in the surgical intensive care unit: a multi-institutional study. Mycoses. 2006 May; 49(3):226-31.Mycoses2006-05-01T00:00:002006Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.16691620Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RECancerRecombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer. 2006 Jun 15; 106(12):2664-71.Cancer2006-06-15T00:00:002006Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.17194825Lewis RE, Chamilos G, Prince RA, Kontoyiannis DPAntimicrobial agents and chemotherapyPretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice. Antimicrob Agents Chemother. 2007 Mar; 51(3):1078-81.Antimicrob Agents Chemother2006-12-28T00:00:002006Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice.17526090Kontoyiannis DP, Lewis REThe New England journal of medicinePosaconazole prophylaxis in hematologic cancer. N Engl J Med. 2007 May 24; 356(21):2214-5; author reply 2215-8.N Engl J Med2007-05-24T00:00:002007Posaconazole prophylaxis in hematologic cancer.17804077Mulanovich V, Lewis RE, Raad II, Kontoyiannis DPThe Journal of infectionRandom plasma concentrations of voriconazole decline over time. J Infect. 2007 Nov; 55(5):e129-30.J Infect2007-09-05T00:00:002007Random plasma concentrations of voriconazole decline over time.18212113Chamilos G, Lewis RE, Lamaris GA, Albert ND, Kontoyiannis DPAntimicrobial agents and chemotherapyGenomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 2008 Apr; 52(4):1325-9.Antimicrob Agents Chemother2008-01-22T00:00:002008Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.18224662Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad IICancerAmphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer. 2008 Mar 15; 112(6):1282-7.Cancer2008-03-15T00:00:002008Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.18412153Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad ICancerThe changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer. 2008 Jun; 112(11):2493-9.Cancer2008-06-01T00:00:002008The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.18583479Chamilos G, Lewis RE, Hu J, Xiao L, Zal T, Gilliet M, Halder G, Kontoyiannis DPProceedings of the National Academy of Sciences of the United States of AmericaDrosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci U S A. 2008 Jul 08; 105(27):9367-72.Proc Natl Acad Sci U S A2008-06-26T00:00:002008Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis.18608886Qiao J, Kontoyiannis DP, Calderone R, Li D, Ma Y, Wan Z, Li R, Liu WMedical mycologyAfyap1, encoding a bZip transcriptional factor of Aspergillus fumigatus, contributes to oxidative stress response but is not essential to the virulence of this pathogen in mice immunosuppressed by cyclophosphamide and triamcinolone. Med Mycol. 2008 Dec; 46(8):773-82.Med Mycol2008-12-01T00:00:002008Afyap1, encoding a bZip transcriptional factor of Aspergillus fumigatus, contributes to oxidative stress response but is not essential to the virulence of this pathogen in mice immunosuppressed by cyclophosphamide and triamcinolone.18637757Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BEClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaDefining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008 Sep 01; 47(5):674-83.Clin Infect Dis2008-09-01T00:00:002008Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.19147091Kontoyiannis DP, Lewis RE, Marr KBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationThe burden of bacterial and viral infections in hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2009 Jan; 15(1 Suppl):128-33.Biol Blood Marrow Transplant2009-01-01T00:00:002009The burden of bacterial and viral infections in hematopoietic stem cell transplant.19324271Yang Z, Kontoyiannis DP, Wen X, Xiong C, Zhang R, Albert ND, Li CNuclear medicine and biologyGamma scintigraphy imaging of murine invasive pulmonary aspergillosis with a (111)In-labeled cyclic peptide. Nucl Med Biol. 2009 Apr; 36(3):259-66.Nucl Med Biol2009-04-01T00:00:002009Gamma scintigraphy imaging of murine invasive pulmonary aspergillosis with a (111)In-labeled cyclic peptide.19619044Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaEchinocandin-based initial therapy in fungemic patients with cancer: a focus on recent guidelines of the infectious diseases society of america. Clin Infect Dis. 2009 Aug 15; 49(4):638-9; author reply 639-40.Clin Infect Dis2009-08-15T00:00:002009Echinocandin-based initial therapy in fungemic patients with cancer: a focus on recent guidelines of the infectious diseases society of america.19634156Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, Kontoyiannis DPCancerCandidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer. 2009 Oct 15; 115(20):4745-52.Cancer2009-10-15T00:00:002009Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.19635953Pongas GN, Ben-Ami R, Lewis RE, Walsh TJ, Kontoyiannis DPAntimicrobial agents and chemotherapyCulture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis. Antimicrob Agents Chemother. 2009 Oct; 53(10):4569.Antimicrob Agents Chemother2009-07-27T00:00:002009Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis.19805674Ravandi F, Aribi A, O'Brien S, Faderl S, Jones D, Ferrajoli A, Huang X, York S, Pierce S, Wierda W, Kontoyiannis D, Verstovsek S, Pro B, Fayad L, Keating M, Kantarjian HJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms. J Clin Oncol. 2009 Nov 10; 27(32):5425-30.J Clin Oncol2009-10-05T00:00:002009Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms.19858263Ben-Ami R, Lewis RE, Tarrand J, Leventakos K, Kontoyiannis DPAntimicrobial agents and chemotherapyAntifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection. Antimicrob Agents Chemother. 2010 Jan; 54(1):484-90.Antimicrob Agents Chemother2009-10-26T00:00:002009Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection.20016020Kofteridis DP, Lewis RE, Kontoyiannis DPThe Journal of antimicrobial chemotherapyCaspofungin-non-susceptible Candida isolates in cancer patients. J Antimicrob Chemother. 2010 Feb; 65(2):293-5.J Antimicrob Chemother2009-12-16T00:00:002009Caspofungin-non-susceptible Candida isolates in cancer patients.20038242Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Dupont HL, Adachi JAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaEscherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis. 2010 Feb 01; 50(3):374-80.Clin Infect Dis2010-02-01T00:00:002010Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies.20138081Campo M, Lewis RE, Kontoyiannis DPThe Journal of infectionInvasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect. 2010 May; 60(5):331-7.J Infect2010-02-04T00:00:002010Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.20811212Feldman EM, Kontoyiannis DP, Sharabi SE, Lee E, Kaufman Y, Heller LPlastic and reconstructive surgeryBreast implant infections: is cefazolin enough? Plast Reconstr Surg. 2010 Sep; 126(3):779-785.Plast Reconstr Surg2010-09-01T00:00:002010Breast implant infections: is cefazolin enough?21178441Kontoyiannis DPVirulenceManipulation of host angioneogenesis: A critical link for understanding the pathogenesis of invasive mold infections? Virulence. 2010 May-Jun; 1(3):192-6.Virulence2010-05-01T00:00:002010Manipulation of host angioneogenesis: A critical link for understanding the pathogenesis of invasive mold infections?21246537Sampsonas F, Kontoyiannis DP, Dickey BF, Evans SECancerPerformance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study. Cancer. 2011 Aug 01; 117(15):3424-33.Cancer2011-01-18T00:00:002011Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study.21396475Khan H, Oberoi S, Mahvash A, Sharma M, Rondon G, Alousi A, Shpall EJ, Kontoyiannis DP, Champlin RE, Ciurea SOBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationReversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement. Biol Blood Marrow Transplant. 2011 Oct; 17(10):1551-5.Biol Blood Marrow Transplant2011-03-09T00:00:002011Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement.21467021Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaThe diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis. 2011 May; 52(9):1144-55.Clin Infect Dis2011-05-01T00:00:002011The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.21486855Lewis RE, Liao G, Hou J, Prince RA, Kontoyiannis DPThe Journal of antimicrobial chemotherapyComparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus. J Antimicrob Chemother. 2011 Jun; 66(6):1324-31.J Antimicrob Chemother2011-04-11T00:00:002011Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus.21502086Kontoyiannis DPThe Journal of infectious diseasesAre serum cytokines sensitive and specific enough to prognosticate in aspergillosis? J Infect Dis. 2011 May 15; 203(10):1503; author reply 1504.J Infect Dis2011-05-15T00:00:002011Are serum cytokines sensitive and specific enough to prognosticate in aspergillosis?21788730Lewis RE, Liao G, Wang W, Prince RA, Kontoyiannis DPVirulenceVoriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection. Virulence. 2011 Jul-Aug; 2(4):348-55.Virulence2011-07-01T00:00:002011Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.22103347Cahuayme-Zuniga L, Lewis RE, Mulanovich VE, Kontoyiannis DPMedical mycologyWeekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies. Med Mycol. 2012 Jul; 50(5):543-8.Med Mycol2011-11-22T00:00:002011Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies.22196206Kontoyiannis DPThe American journal of medicineInvasive mycoses: strategies for effective management. Am J Med. 2012 Jan; 125(1 Suppl):S25-38.Am J Med2012-01-01T00:00:002012Invasive mycoses: strategies for effective management.22247441Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPathogenesis of mucormycosis. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S16-22.Clin Infect Dis2012-02-01T00:00:002012Pathogenesis of mucormycosis.22247450Kontoyiannis DP, Lewis RE, Lortholary O, Lotholary O, Spellberg B, Petrikkos G, Roilides E, Roillides E, Ibrahim A, Walsh TJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaFuture directions in mucormycosis research. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S79-85.Clin Infect Dis2012-02-01T00:00:002012Future directions in mucormycosis research.22580034Georgiadou SP, Kontoyiannis DPThe Journal of infectionConcurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis? J Infect. 2012 Sep; 65(3):262-8.J Infect2012-05-09T00:00:002012Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis?22686246Petraitis V, Petraitiene R, Antachopoulos C, Hughes JE, Cotton MP, Kasai M, Harrington S, Gamaletsou MN, Bacher JD, Kontoyiannis DP, Roilides E, Walsh TJMedical mycologyIncreased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism. Med Mycol. 2013 Jan; 51(1):72-82.Med Mycol2012-06-11T00:00:002012Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.23166189Farmakiotis D, Tverdek FP, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaThe safety of amphotericin B lipid complex in patients with prior severe intolerance to liposomal amphotericin B. Clin Infect Dis. 2013 Mar; 56(5):701-3.Clin Infect Dis2012-11-19T00:00:002012The safety of amphotericin B lipid complex in patients with prior severe intolerance to liposomal amphotericin B.23303813Ben-Ami R, Albert ND, Lewis RE, Kontoyiannis DPThe Journal of infectious diseasesProangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis. J Infect Dis. 2013 Apr; 207(7):1066-74.J Infect Dis2013-01-09T00:00:002013Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis.29438475Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR, Garey KW, Reboli A, Greenberg RN, Apewokin S, Lyon GM, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AMClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaDetecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel. Clin Infect Dis. 2018 05 17; 66(11):1678-1686.Clin Infect Dis2018-05-17T00:00:002018Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.23349440Lewis RE, Albert NP, Liao G, Wang W, Prince RA, Kontoyiannis DPThe Journal of antimicrobial chemotherapyHigh-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia. J Antimicrob Chemother. 2013 May; 68(5):1148-51.J Antimicrob Chemother2013-01-24T00:00:002013High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia.23384532Pappas PG, Kontoyiannis DP, Perfect JR, Chiller TMAntimicrobial agents and chemotherapyReal-time treatment guidelines: considerations during the Exserohilum rostratum outbreak in the United States. Antimicrob Agents Chemother. 2013 Apr; 57(4):1573-6.Antimicrob Agents Chemother2013-02-05T00:00:002013Real-time treatment guidelines: considerations during the Exserohilum rostratum outbreak in the United States.23780464Thompson GR, Kontoyiannis DP, Patterson TFJAMAReal-world experience in the midst of an Exserohilum meningitis outbreak. JAMA. 2013 Jun 19; 309(23):2493-5.JAMA2013-06-19T00:00:002013Real-world experience in the midst of an Exserohilum meningitis outbreak.Authorship 88769310Authorship 88933611Authorship 8899775Authorship 8901464D009181Disorders1503850.74209MycosesD009091Disorders491080.873027MucormycosisD000935Chemicals & Drugs2198340.631958Antifungal AgentsD014230Chemicals & Drugs2606100.706246TriazolesD001228Disorders722430.833866AspergillosisAuthorship 9042852Authorship 9044995Authorship 9056337Authorship 9057471Authorship 9057837Authorship 9057863Authorship 9062043Authorship 9062968Authorship 9066009Authorship 9072884Authorship 9074783Authorship 9077292Authorship 9088654Authorship 9090133Authorship 9093651Authorship 9093677Authorship 9098745Authorship 9099341Authorship 9107335Authorship 9109198Authorship 9111227Authorship 9112565Authorship 9115102Authorship 9120291Authorship 9121037Authorship 9129197Authorship 9131486Authorship 9134474Authorship 9147592Authorship 9148122Authorship 9148722Authorship 9149382Authorship 9155348Authorship 9162256Authorship 9168115Authorship 9169662Authorship 9170491Authorship 9175125Authorship 9188991Authorship 9192622Authorship 9202173Authorship 9223555Authorship 9229383Authorship 9230474Authorship 9237284Authorship 9241134Authorship 9243822Authorship 9247548Authorship 9248534Authorship 92500510Authorship 9255693Authorship 9256513Authorship 92580112Authorship 9272081Authorship 9275122Authorship 9277541Authorship 9288324Authorship 9292381Authorship 9294654Authorship 9299643Authorship 93025416Authorship 9303002Authorship 9315442Authorship 93201816Authorship 9344657Authorship 93501218Authorship 9353875Authorship 9354533Authorship 9360904Authorship 9361273Authorship 9366053Authorship 93875710Authorship 9397874Authorship 939960325989947Davoudi S, Graviss LS, Kontoyiannis DPEuropean journal of clinical investigationHealthcare-associated outbreaks due to Mucorales and other uncommon fungi. Eur J Clin Invest. 2015 Jul; 45(7):767-73.Eur J Clin Invest2015-07-01T00:00:002015Healthcare-associated outbreaks due to Mucorales and other uncommon fungi.26684607Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJLancet (London, England)Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016 Feb 20; 387(10020):760-9.Lancet2015-12-10T00:00:002015Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.26747101Ben Yaakov D, Rivkin A, Mircus G, Albert N, Dietl AM, Kovalerchick D, Carmeli S, Haas H, Kontoyiannis DP, Osherov NThe Journal of antimicrobial chemotherapyIdentification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis. J Antimicrob Chemother. 2016 Apr; 71(4):946-52.J Antimicrob Chemother2016-01-07T00:00:002016Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis.26897065Farmakiotis D, Kontoyiannis DPInfectious disease clinics of North AmericaMucormycoses. Infect Dis Clin North Am. 2016 Mar; 30(1):143-63.Infect Dis Clin North Am2016-03-01T00:00:002016Mucormycoses.26945845Nigo M, Vial MR, Munita JM, Jiang Y, Tarrand J, Jimenez CA, Kontoyiannis DPThe Journal of infectionFungal empyema thoracis in cancer patients. J Infect. 2016 May; 72(5):615-21.J Infect2016-03-02T00:00:002016Fungal empyema thoracis in cancer patients.27020939Healey KR, Zhao Y, Perez WB, Lockhart SR, Sobel JD, Farmakiotis D, Kontoyiannis DP, Sanglard D, Taj-Aldeen SJ, Alexander BD, Jimenez-Ortigosa C, Shor E, Perlin DSNature communicationsPrevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance. Nat Commun. 2016 Mar 29; 7:11128.Nat Commun2016-03-29T00:00:002016Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance.26643329Ioannou P, Andrianaki A, Akoumianaki T, Kyrmizi I, Albert N, Perlin D, Samonis G, Kontoyiannis DP, Chamilos GAntimicrobial agents and chemotherapyAlbumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae. Antimicrob Agents Chemother. 2015 Dec 07; 60(3):1226-33.Antimicrob Agents Chemother2015-12-07T00:00:002015Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.26858961Gamaletsou MN, Rammaert B, Bueno MA, Sipsas NV, Moriyama B, Kontoyiannis DP, Roilides E, Zeller V, Taj-Aldeen SJ, Miller AO, Petraitiene R, Lortholary O, Walsh TJOpen forum infectious diseasesCandida Arthritis: Analysis of 112 Pediatric and Adult Cases. Open Forum Infect Dis. 2016 Jan; 3(1):ofv207.Open Forum Infect Dis2015-12-23T00:00:002015Candida Arthritis: Analysis of 112 Pediatric and Adult Cases.27159390Gebremariam T, Lin L, Liu M, Kontoyiannis DP, French S, Edwards JE, Filler SG, Ibrahim ASThe Journal of clinical investigationBicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis. J Clin Invest. 2016 06 01; 126(6):2280-94.J Clin Invest2016-05-09T00:00:002016Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis.27367980Tatara AM, Mikos AG, Kontoyiannis DPMedicineFactors affecting patient outcome in primary cutaneous aspergillosis. Medicine (Baltimore). 2016 Jun; 95(26):e3747.Medicine (Baltimore)2016-06-01T00:00:002016Factors affecting patient outcome in primary cutaneous aspergillosis.27365388Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JEClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 08 15; 63(4):e1-e60.Clin Infect Dis2016-06-29T00:00:002016Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.27433413Kyvernitakis A, Azzi J, Kontoyiannis DPCureusMixed Mycobacterium Avium-Intracellulare and Serratia Marcescens Cellulitis of the Breast in an HIV-Negative Patient with Breast Cancer: A Case Report. Cureus. 2016 Jun 09; 8(6):e634.Cureus2016-06-09T00:00:002016Mixed Mycobacterium Avium-Intracellulare and Serratia Marcescens Cellulitis of the Breast in an HIV-Negative Patient with Breast Cancer: A Case Report.27133559Stempel JM, Farmakiotis D, Tarrand JJ, Kontoyiannis DPDiagnostic microbiology and infectious diseaseTime-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patients. Diagn Microbiol Infect Dis. 2016 Jul; 85(3):391-393.Diagn Microbiol Infect Dis2016-04-07T00:00:002016Time-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patients.27191199Chitasombat MN, Kontoyiannis DPCurrent opinion in infectious diseasesTreatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents. Curr Opin Infect Dis. 2016 08; 29(4):340-5.Curr Opin Infect Dis2016-08-01T00:00:002016Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents.27275514Tverdek FP, Kofteridis D, Kontoyiannis DPExpert review of anti-infective therapyAntifungal agents and liver toxicity: a complex interaction. Expert Rev Anti Infect Ther. 2016 08; 14(8):765-76.Expert Rev Anti Infect Ther2016-06-23T00:00:002016Antifungal agents and liver toxicity: a complex interaction.27341684Jain P, Nagarajan P, Prayag P, Benton CB, Kadia T, Groisberg R, Kontoyiannis DP, Mulanovich VE, Pemmaraju NAmerican journal of hematologyMixed angioinvasive exserohilum and scedosporium infection in a patient with AML. Am J Hematol. 2017 Jan; 92(1):119-120.Am J Hematol2016-07-14T00:00:002016Mixed angioinvasive exserohilum and scedosporium infection in a patient with AML.27481947Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JEClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaExecutive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 08 15; 63(4):433-42.Clin Infect Dis2016-08-15T00:00:002016Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.27562862Osherov N, Kontoyiannis DPMedical mycologyThe anti-Aspergillus drug pipeline: Is the glass half full or empty? Med Mycol. 2017 Jan 01; 55(1):118-124.Med Mycol2016-08-25T00:00:002016The anti-Aspergillus drug pipeline: Is the glass half full or empty?26984141Bellanger AP, Tatara AM, Shirazi F, Gebremariam T, Albert ND, Lewis RE, Ibrahim AS, Kontoyiannis DPThe Journal of infectious diseasesStatin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae. J Infect Dis. 2016 07 01; 214(1):114-21.J Infect Dis2016-03-16T00:00:002016Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.27254038Aitken SL, Kontoyiannis DP, DePombo AM, Bhatti MM, Tverdek FP, Gettys SC, Nicolau DP, Nunez CAThe Pediatric infectious disease journalUse of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient. Pediatr Infect Dis J. 2016 09; 35(9):1040-2.Pediatr Infect Dis J2016-09-01T00:00:002016Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient.27986674Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaWhat to Do for the Asymptomatic Pulmonary Coccidioidal Nodule or Cavity in Immunosuppressed Patients? A Focus in the Recent Coccidioidomycosis Guidelines. Clin Infect Dis. 2017 01 15; 64(2):232-233.Clin Infect Dis2016-11-09T00:00:002016What to Do for the Asymptomatic Pulmonary Coccidioidal Nodule or Cavity in Immunosuppressed Patients? A Focus in the Recent Coccidioidomycosis Guidelines.27993850Lionakis MS, Albert ND, Swamydas M, Lee CR, Loetscher P, Kontoyiannis DPAntimicrobial agents and chemotherapyPharmacological Blockade of the Chemokine Receptor CCR1 Protects Mice from Systemic Candidiasis of Hematogenous Origin. Antimicrob Agents Chemother. 2017 03; 61(3).Antimicrob Agents Chemother2017-02-23T00:00:002017Pharmacological Blockade of the Chemokine Receptor CCR1 Protects Mice from Systemic Candidiasis of Hematogenous Origin.27791470Kontoyiannis DPVirulenceInfections following allogeneic stem cell transplantation: New concepts, improved insights, and renewed hope for better outcomes. Virulence. 2016 11 16; 7(8):898-900.Virulence2016-11-16T00:00:002016Infections following allogeneic stem cell transplantation: New concepts, improved insights, and renewed hope for better outcomes.27942540Kontoyiannis DPOpen forum infectious diseasesA Potential Explanation of a Positive Serum ?-Glucan Assay in Mucormycosis. Open Forum Infect Dis. 2016 Oct; 3(4):ofw209.Open Forum Infect Dis2016-12-08T00:00:002016A Potential Explanation of a Positive Serum ?-Glucan Assay in Mucormycosis.28053147Taj-Aldeen SJ, Gamaletsou MN, Rammaert B, Sipsas NV, Zeller V, Roilides E, Kontoyiannis DP, Henry M, Petraitis V, Moriyama B, Denning DW, Lortholary O, Walsh TJ, International Osteoarticular Mycoses
ConsortiumMedical mycologyBone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century. Med Mycol. 2017 Oct 01; 55(7):691-704.Med Mycol2017-10-01T00:00:002017Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century.27609563Gamaletsou MN, Rammaert B, Bueno MA, Sipsas NV, Moriyama B, Kontoyiannis DP, Roilides E, Zeller V, Taj-Aldeen SJ, Henry M, Petraitis V, Denning DW, Lortholary O, Walsh TJ, International Osteoarticular Mycoses ConsortiumMedical mycologyAspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases. Med Mycol. 2017 Apr 01; 55(3):246-254.Med Mycol2017-04-01T00:00:002017Aspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases.27677095Pemmaraju N, Jain P, Medeiros LJ, Jorgenson JL, Jain N, Willis J, Kontoyiannis DP, Estrov Z, Wierda WGAmerican journal of hematologyPET-positive lymphadenopathy in CLL-Not always Richter transformation. Am J Hematol. 2017 04; 92(4):405-406.Am J Hematol2017-02-07T00:00:002017PET-positive lymphadenopathy in CLL-Not always Richter transformation.27905900Kontoyiannis DP, Yang H, Song J, Kelkar SS, Yang X, Azie N, Harrington R, Fan A, Lee E, Spalding JRBMC infectious diseasesPrevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study. BMC Infect Dis. 2016 12 01; 16(1):730.BMC Infect Dis2016-12-01T00:00:002016Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study.28379304Heo ST, Tatara AM, Jim?nez-Ortigosa C, Jiang Y, Lewis RE, Tarrand J, Tverdek F, Albert ND, Verweij PE, Meis JF, Mikos AG, Perlin DS, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaChanges in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015. Clin Infect Dis. 2017 Jul 15; 65(2):216-225.Clin Infect Dis2017-07-15T00:00:002017Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.28486802Tatara AM, Watson E, Satish T, Scott DW, Kontoyiannis DP, Engel PS, Mikos AGBiomacromoleculesSynthesis and Characterization of Diol-Based Unsaturated Polyesters: Poly(diol fumarate) and Poly(diol fumarate-co-succinate). Biomacromolecules. 2017 Jun 12; 18(6):1724-1735.Biomacromolecules2017-05-17T00:00:002017Synthesis and Characterization of Diol-Based Unsaturated Polyesters: Poly(diol fumarate) and Poly(diol fumarate-co-succinate).28357242Shirazi F, Kontoyiannis DPMicrobial cell (Graz, Austria)Heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against Scedosporium prolificans via induction of apoptosis. Microb Cell. 2014 Jun 02; 1(6):179-188.Microb Cell2014-06-02T00:00:002014Heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against Scedosporium prolificans via induction of apoptosis.28357269Shirazi F, Lewis RE, Kontoyiannis DPMicrobial cell (Graz, Austria)Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin. Microb Cell. 2015 Oct 23; 2(11):445-450.Microb Cell2015-10-23T00:00:002015Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin.28475687Ben Yaakov D, Shadkchan Y, Albert N, Kontoyiannis DP, Osherov NThe Journal of antimicrobial chemotherapyThe quinoline bromoquinol exhibits broad-spectrum antifungal activity and induces oxidative stress and apoptosis in Aspergillus fumigatus. J Antimicrob Chemother. 2017 08 01; 72(8):2263-2272.J Antimicrob Chemother2017-08-01T00:00:002017The quinoline bromoquinol exhibits broad-spectrum antifungal activity and induces oxidative stress and apoptosis in Aspergillus fumigatus.28597967Kontoyiannis DP, Bassetti M, Nucci M, Capparella MR, Yan JL, Aram J, Hogan PAMycosesAnidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies. Mycoses. 2017 Oct; 60(10):663-667.Mycoses2017-06-09T00:00:002017Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies.28669831Farmakiotis D, Kontoyiannis DPInternational journal of antimicrobial agentsEpidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management. Int J Antimicrob Agents. 2017 Sep; 50(3):318-324.Int J Antimicrob Agents2017-06-29T00:00:002017Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management.28584138Le A, Farmakiotis D, Tarrand JJ, Kontoyiannis DPAntimicrobial agents and chemotherapyInitial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole? Antimicrob Agents Chemother. 2017 08; 61(8).Antimicrob Agents Chemother2017-07-25T00:00:002017Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?28507111Tverdek FP, Heo ST, Aitken SL, Granwehr B, Kontoyiannis DPAntimicrobial agents and chemotherapyReal-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses. Antimicrob Agents Chemother. 2017 08; 61(8).Antimicrob Agents Chemother2017-07-25T00:00:002017Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses.29121264Foolad F, Kontoyiannis DPThe Journal of antimicrobial chemotherapyPersistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels. J Antimicrob Chemother. 2018 01 01; 73(1):256-258.J Antimicrob Chemother2018-01-01T00:00:002018Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels.29128228Sagiv O, Thakar SD, Kandl TJ, Kontoyiannis DP, Debnam JM, Esmaeli BOphthalmologyClinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer. Ophthalmology. 2018 02; 125(2):318-320.Ophthalmology2017-11-08T00:00:002017Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer.28919347Economides MP, Ballester LY, Kumar VA, Jiang Y, Tarrand J, Prieto V, Torres HA, Kontoyiannis DPThe Journal of infectionInvasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often. J Infect. 2017 12; 75(6):572-580.J Infect2017-09-14T00:00:002017Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often.28911042McCarthy MW, Kontoyiannis DP, Cornely OA, Perfect JR, Walsh TJThe Journal of infectious diseasesNovel Agents and Drug Targets to Meet the Challenges of Resistant Fungi. J Infect Dis. 2017 08 15; 216(suppl_3):S474-S483.J Infect Dis2017-08-15T00:00:002017Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi.28911044Kontoyiannis DPThe Journal of infectious diseasesAntifungal Resistance: An Emerging Reality and A Global Challenge. J Infect Dis. 2017 08 15; 216(suppl_3):S431-S435.J Infect Dis2017-08-15T00:00:002017Antifungal Resistance: An Emerging Reality and A Global Challenge.28914100Mulanovich V, Kontoyiannis DPLeukemia & lymphomaAcute myeloid leukemia and the infectious diseases consultant. Leuk Lymphoma. 2018 06; 59(6):1284-1291.Leuk Lymphoma2017-09-15T00:00:002017Acute myeloid leukemia and the infectious diseases consultant.29029010Chamilos G, Lionakis MS, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaCall for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways. Clin Infect Dis. 2018 01 06; 66(1):140-148.Clin Infect Dis2018-01-06T00:00:002018Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.29194488Kontoyiannis DP, Selleslag D, Mullane K, Cornely OA, Hope W, Lortholary O, Croos-Dabrera R, Lademacher C, Engelhardt M, Patterson TFThe Journal of antimicrobial chemotherapyImpact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial. J Antimicrob Chemother. 2018 03 01; 73(3):757-763.J Antimicrob Chemother2018-03-01T00:00:002018Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.29693737Cornely OA, Kontoyiannis DPMycosesHow to prophylax against invasive fungal infections in adult ALL? An unmet need. Mycoses. 2018 Sep; 61(9):646-649.Mycoses2018-06-13T00:00:002018How to prophylax against invasive fungal infections in adult ALL? An unmet need.29390110Lamoth F, Kontoyiannis DPThe Journal of infectious diseasesThe Candida auris Alert: Facts and Perspectives. J Infect Dis. 2018 01 30; 217(4):516-520.J Infect Dis2018-01-30T00:00:002018The Candida auris Alert: Facts and Perspectives.29849062Kyrmizi I, Ferreira H, Carvalho A, Figueroa JAL, Zarmpas P, Cunha C, Akoumianaki T, Stylianou K, Deepe GS, Samonis G, Lacerda JF, Campos A, Kontoyiannis DP, Mihalopoulos N, Kwon-Chung KJ, El-Benna J, Valsecchi I, Beauvais A, Brakhage AA, Neves NM, Latge JP, Chamilos GNature microbiologyCalcium sequestration by fungal melanin inhibits calcium-calmodulin signalling to prevent LC3-associated phagocytosis. Nat Microbiol. 2018 07; 3(7):791-803.Nat Microbiol2018-05-30T00:00:002018Calcium sequestration by fungal melanin inhibits calcium-calmodulin signalling to prevent LC3-associated phagocytosis.29221962Tatara AM, Kontoyiannis DP, Mikos AGAdvanced drug delivery reviewsDrug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions. Adv Drug Deliv Rev. 2018 04; 129:319-329.Adv Drug Deliv Rev2017-12-06T00:00:002017Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions.29358941Kumaresan PR, da Silva TA, Kontoyiannis DPFrontiers in immunologyMethods of Controlling Invasive Fungal Infections Using CD8+ T Cells. Front Immunol. 2017; 8:1939.Front Immunol2018-01-08T00:00:002018Methods of Controlling Invasive Fungal Infections Using CD8+ T Cells.29370370Chamilos G, Lionakis MS, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaReply to Bazaz and Denning. Clin Infect Dis. 2018 06 18; 67(1):157-159.Clin Infect Dis2018-06-18T00:00:002018Reply to Bazaz and Denning.29208429Daver N, Kontoyiannis DPThe Lancet. OncologyCheckpoint inhibitors and aspergillosis in AML: the double hit hypothesis. Lancet Oncol. 2017 12; 18(12):1571-1573.Lancet Oncol2017-12-01T00:00:002017Checkpoint inhibitors and aspergillosis in AML: the double hit hypothesis.29280197Liu J, Mouhayar E, Tarrand JJ, Kontoyiannis DPMycosesFulminant Cryptococcus neoformans infection with fatal pericardial tamponade in a patient with chronic myelomonocytic leukaemia who was treated with ruxolitinib: Case report and review of fungal pericarditis. Mycoses. 2018 Apr; 61(4):245-255.Mycoses2018-01-19T00:00:002018Fulminant Cryptococcus neoformans infection with fatal pericardial tamponade in a patient with chronic myelomonocytic leukaemia who was treated with ruxolitinib: Case report and review of fungal pericarditis.29414033Lacourt TE, Kavelaars A, Galloway-Pe?a JR, Sahasrabhojane PV, Shah ND, Futreal A, Kontoyiannis DP, Shelburne SA, Heijnen CJPsychoneuroendocrinologyAssociations of inflammation with symptom burden in patients with acute myeloid leukemia. Psychoneuroendocrinology. 2018 03; 89:203-208.Psychoneuroendocrinology2018-03-01T00:00:002018Associations of inflammation with symptom burden in patients with acute myeloid leukemia.29554829Rausch CR, Kontoyiannis DPJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy PractitionersProlonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicities. J Oncol Pharm Pract. 2019 Apr; 25(3):747-753.J Oncol Pharm Pract2018-03-19T00:00:002018Prolonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicities.29643840Zoran T, Sartori B, Sappl L, Aigner M, S?nchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fern?ndez MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Fl?rl C, Lackner MFrontiers in microbiologyAzole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? Front Microbiol. 2018; 9:516.Front Microbiol2018-03-28T00:00:002018Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?29860307Lionakis MS, Lewis RE, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaBreakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions. Clin Infect Dis. 2018 10 30; 67(10):1621-1630.Clin Infect Dis2018-10-30T00:00:002018Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.29911929Strati P, Gabutti C, Thompson PA, Kontoyiannis DP, Ferrajoli ALeukemia & lymphomaCytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2019 02; 60(2):535-537.Leuk Lymphoma2018-06-18T00:00:002018Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia.30127354Andrianaki AM, Kyrmizi I, Thanopoulou K, Baldin C, Drakos E, Soliman SSM, Shetty AC, McCracken C, Akoumianaki T, Stylianou K, Ioannou P, Pontikoglou C, Papadaki HA, Tzardi M, Belle V, Etienne E, Beauvais A, Samonis G, Kontoyiannis DP, Andreakos E, Bruno VM, Ibrahim AS, Chamilos GNature communicationsIron restriction inside macrophages regulates pulmonary host defense against Rhizopus species. Nat Commun. 2018 08 20; 9(1):3333.Nat Commun2018-08-20T00:00:002018Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species.30131851Lacourt TE, Kavelaars A, Ohanian M, Shah ND, Shelburne SA, Futreal A, Kontoyiannis DP, Heijnen CJOncotargetPatient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia. Oncotarget. 2018 Jul 27; 9(58):31244-31252.Oncotarget2018-07-27T00:00:002018Patient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia.30339235Magira EE, Jiang Y, Kontoyiannis DPMedical mycologyBaseline serum Aspergillus galactomannan index in patients with hematologic malignancy and culture-documented invasive pulmonary aspergillosis: is there a difference among Aspergillus species? Med Mycol. 2019 Jul 01; 57(5):639-642.Med Mycol2019-07-01T00:00:002019Baseline serum Aspergillus galactomannan index in patients with hematologic malignancy and culture-documented invasive pulmonary aspergillosis: is there a difference among Aspergillus species?30408899Chamilos G, Kontoyiannis DPMedical mycologyDefining the diagnosis of invasive aspergillosis. Med Mycol. 2006 Sep 01; 44(Supplement_1):S163-S173.Med Mycol2006-09-01T00:00:002006Defining the diagnosis of invasive aspergillosis.30038934Castillo P, Wright KE, Kontoyiannis DP, Walsh T, Patel S, Chorvinsky E, Bose S, Hazrat Y, Omer B, Albert N, Leen AM, Rooney CM, Bollard CM, Cruz CRYMolecular therapy. Methods & clinical developmentA New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae. Mol Ther Methods Clin Dev. 2018 Jun 15; 9:305-312.Mol Ther Methods Clin Dev2018-03-14T00:00:002018A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae.30323308De la Hoz A, Foolad F, Gallegos C, Kornblau S, Kontoyiannis DPBone marrow transplantationNivolumab-induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin's disease. Bone Marrow Transplant. 2019 05; 54(5):749-751.Bone Marrow Transplant2018-10-15T00:00:002018Nivolumab-induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin's disease.29771293Rausch CR, DiPippo AJ, Bose P, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaBreakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole. Clin Infect Dis. 2018 10 30; 67(10):1610-1613.Clin Infect Dis2018-10-30T00:00:002018Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole.30015364Magira EE, Jiang Y, Economides M, Tarrand J, Kontoyiannis DPMycosesMixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre. Mycoses. 2018 Nov; 61(11):861-867.Mycoses2018-08-01T00:00:002018Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre.30021823Fern?ndez-Cruz A, Magira E, Heo ST, Evans S, Tarrand J, Kontoyiannis DPJournal of clinical microbiologyBronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes. J Clin Microbiol. 2018 10; 56(10).J Clin Microbiol2018-09-25T00:00:002018Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes.30230043DiPippo AJ, Rausch CR, Kontoyiannis DPMycosesTolerability of isavuconazole after posaconazole toxicity in leukaemia patients. Mycoses. 2019 Jan; 62(1):81-86.Mycoses2018-10-24T00:00:002018Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.30525252Potenza L, Chitasombat MN, Klimko N, Bettelli F, Dragonetti G, Del Principe MI, Nucci M, Busca A, Fracchiolla N, Scium? M, Spolzino A, Delia M, Mancini V, Nadali GP, Dargenio M, Shadrivova O, Bacchelli F, Aversa F, Sanguinetti M, Luppi M, Kontoyiannis DP, Pagano LMycosesRhodotorula infection in haematological patient: Risk factors and outcome. Mycoses. 2019 Mar; 62(3):223-229.Mycoses2018-12-28T00:00:002018Rhodotorula infection in haematological patient: Risk factors and outcome.30648453Alfayez M, Wang SA, Bannon SA, Kontoyiannis DP, Kornblau SM, Orange JS, Mace EM, DiNardo CDLeukemia & lymphomaMyeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype. Leuk Lymphoma. 2019 08; 60(8):2025-2033.Leuk Lymphoma2019-01-16T00:00:002019Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype.30467313Andrianaki AM, Kyrmizi I, Thanopoulou K, Baldin C, Drakos E, Soliman SSM, Shetty AC, McCracken C, Akoumianaki T, Stylianou K, Ioannou P, Pontikoglou C, Papadaki HA, Tzardi M, Belle V, Etienne E, Beauvais A, Samonis G, Kontoyiannis DP, Andreakos E, Bruno VM, Ibrahim AS, Chamilos GNature communicationsAuthor Correction: Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species. Nat Commun. 2018 11 22; 9(1):5015.Nat Commun2018-11-22T00:00:002018Author Correction: Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species.30692970Zoran T, Sartori B, Sappl L, Aigner M, S?nchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fern?ndez MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Fl?rl C, Lackner MFrontiers in microbiologyCorrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? Front Microbiol. 2018; 9:3245.Front Microbiol2019-01-14T00:00:002019Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?30299361Yong MK, Slavin MA, Kontoyiannis DPCurrent opinion in infectious diseasesInvasive fungal disease and cytomegalovirus infection: is there an association? Curr Opin Infect Dis. 2018 12; 31(6):481-489.Curr Opin Infect Dis2018-12-01T00:00:002018Invasive fungal disease and cytomegalovirus infection: is there an association?30455245Wurster S, Lewis RE, Albert ND, Kontoyiannis DPAntimicrobial agents and chemotherapyPreexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model. Antimicrob Agents Chemother. 2019 02; 63(2).Antimicrob Agents Chemother2019-01-29T00:00:002019Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.University of Houston College of PharmacyKEVINGAREYKEVIN W. GAREY29.70508570000000-95.401808700000004636GAREY, KEVINProfessor. Chair, Department of Pharmacy Practice and Translational Research.Authorship 9410732Authorship 9417764Authorship 942508530803970Mason MJ, McDaneld PM, Musick WL, Kontoyiannis DPAntimicrobial agents and chemotherapySerum Levels of Crushed Posaconazole Delayed-Release Tablets. Antimicrob Agents Chemother. 2019 05; 63(5).Antimicrob Agents Chemother2019-04-25T00:00:002019Serum Levels of Crushed Posaconazole Delayed-Release Tablets.30861066DiPippo AJ, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaLack of Toxicity With Long-term Isavuconazole Use in Patients With Hematologic Malignancy. Clin Infect Dis. 2019 10 15; 69(9):1624-1627.Clin Infect Dis2019-10-15T00:00:002019Lack of Toxicity With Long-term Isavuconazole Use in Patients With Hematologic Malignancy.30882993Tatara AM, Watson E, Albert ND, Kontoyiannis PD, Kontoyiannis DP, Mikos AGJournal of biomedical materials research. Part AA murine model of cutaneous aspergillosis for evaluation of biomaterials-based local delivery therapies. J Biomed Mater Res A. 2019 09; 107(9):1867-1874.J Biomed Mater Res A2019-04-07T00:00:002019A murine model of cutaneous aspergillosis for evaluation of biomaterials-based local delivery therapies.Authorship 944529130974130Stanzani M, Vianelli N, Cavo M, Kontoyiannis DP, Lewis REThe Journal of infectionDevelopment and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies. J Infect. 2019 06; 78(6):484-490.J Infect2019-04-08T00:00:002019Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies.Authorship 945774131024975Kontoyiannis DP, Shah EC, Wurster S, Aitken SL, Graviss L, Raad II, Chemaly RFOpen forum infectious diseasesCulture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey. Open Forum Infect Dis. 2019 Apr; 6(4):ofz138.Open Forum Infect Dis2019-04-02T00:00:002019Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey.Authorship 946224731036689Vargas-Cruz N, Reitzel RA, Rosenblatt J, Chaftari AM, Wilson Dib R, Hachem R, Kontoyiannis DP, Raad IIAntimicrobial agents and chemotherapyNitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm. Antimicrob Agents Chemother. 2019 07; 63(7).Antimicrob Agents Chemother2019-06-24T00:00:002019Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm.Authorship 9466391531065565Galloway-Pe?a JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PCOpen forum infectious diseasesFecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Open Forum Infect Dis. 2019 May; 6(5):ofz173.Open Forum Infect Dis2019-04-04T00:00:002019Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study.23163595Kontoyiannis DP, Georgiadou SP, Wierda WG, Wright S, Albert ND, Ferrajoli A, Keating M, Lewis RELeukemia & lymphomaImpaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2013 Aug; 54(8):1730-3.Leuk Lymphoma2013-02-20T00:00:002013Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia.23551865Lewis RE, Cahyame-Zuniga L, Leventakos K, Chamilos G, Ben-Ami R, Tamboli P, Tarrand J, Bodey GP, Luna M, Kontoyiannis DPMycosesEpidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013 Nov; 56(6):638-45.Mycoses2013-04-04T00:00:002013Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study.23611830Zanette RA, Kontoyiannis DPVirulencePre-exposure of Candida species to cytarabine and daunorubicin does not affect their in vitro antifungal susceptibility and virulence in flies. Virulence. 2013 May 15; 4(4):344-6.Virulence2013-04-23T00:00:002013Pre-exposure of Candida species to cytarabine and daunorubicin does not affect their in vitro antifungal susceptibility and virulence in flies.23650291Kontoyiannis DP, Perlin DS, Roilides E, Walsh TJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaWhat can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis? Clin Infect Dis. 2013 Sep; 57(6):853-9.Clin Infect Dis2013-05-06T00:00:002013What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis?23769840Farmakiotis D, Ciurea AM, Cahuayme-Zuniga L, Kontoyiannis DPThe Journal of infectionThe diagnostic yield of skin biopsy in patients with leukemia and suspected infection. J Infect. 2013 Oct; 67(4):265-72.J Infect2013-06-14T00:00:002013The diagnostic yield of skin biopsy in patients with leukemia and suspected infection.23817366Shirazi F, Pontikos MA, Walsh TJ, Albert N, Lewis RE, Kontoyiannis DPAntimicrobial agents and chemotherapyHyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis. Antimicrob Agents Chemother. 2013 Sep; 57(9):4360-8.Antimicrob Agents Chemother2013-07-01T00:00:002013Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis.23817424Kyrmizi I, Gresnigt MS, Akoumianaki T, Samonis G, Sidiropoulos P, Boumpas D, Netea MG, van de Veerdonk FL, Kontoyiannis DP, Chamilos GJournal of immunology (Baltimore, Md. : 1950)Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling. J Immunol. 2013 Aug 01; 191(3):1287-99.J Immunol2013-07-01T00:00:002013Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling.23836166Kaluarachchi WD, Cisneros BT, Corr SJ, Albert ND, Curley SA, Kontoyiannis DPAntimicrobial agents and chemotherapyAspergillus fumigatus hyphal damage caused by noninvasive radiofrequency field-induced hyperthermia. Antimicrob Agents Chemother. 2013 Sep; 57(9):4444-8.Antimicrob Agents Chemother2013-07-08T00:00:002013Aspergillus fumigatus hyphal damage caused by noninvasive radiofrequency field-induced hyperthermia.23863608Zanette RA, Kontoyiannis DPVirulenceParadoxical effect to caspofungin in Candida species does not confer survival advantage in a Drosophila model of candidiasis. Virulence. 2013 Aug 15; 4(6):497-8.Virulence2013-06-26T00:00:002013Paradoxical effect to caspofungin in Candida species does not confer survival advantage in a Drosophila model of candidiasis.24020743Lewis RE, Kontoyiannis DPFuture microbiologyEpidemiology and treatment of mucormycosis. Future Microbiol. 2013 Sep; 8(9):1163-75.Future Microbiol2013-09-01T00:00:002013Epidemiology and treatment of mucormycosis.24098573Barbu EM, Shirazi F, McGrath DM, Albert N, Sidman RL, Pasqualini R, Arap W, Kontoyiannis DPPloS oneAn antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosis. PLoS One. 2013; 8(10):e76981.PLoS One2013-10-03T00:00:002013An antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosis.24126718Ibrahim AS, Kontoyiannis DPCurrent opinion in infectious diseasesUpdate on mucormycosis pathogenesis. Curr Opin Infect Dis. 2013 Dec; 26(6):508-15.Curr Opin Infect Dis2013-12-01T00:00:002013Update on mucormycosis pathogenesis.Authorship 9478096Authorship 9480759Authorship 948288231145717Chow NA, Toda M, Pennington AF, Anassi E, Atmar RL, Cox-Ganser JM, Da Silva J, Garcia B, Kontoyiannis DP, Ostrosky-Zeichner L, Leining LM, McCarty J, Al Mohajer M, Murthy BP, Park JH, Schulte J, Shuford JA, Skrobarcek KA, Solomon S, Strysko J, Chiller TM, Jackson BR, Chew GL, Beer KDMMWR. Morbidity and mortality weekly reportHurricane-Associated Mold Exposures Among Patients at Risk for Invasive Mold Infections After Hurricane Harvey - Houston, Texas, 2017. MMWR Morb Mortal Wkly Rep. 2019 May 31; 68(21):469-473.MMWR Morb Mortal Wkly Rep2019-05-31T00:00:002019Hurricane-Associated Mold Exposures Among Patients at Risk for Invasive Mold Infections After Hurricane Harvey - Houston, Texas, 2017.31138745Wurster S, Kumaresan PR, Albert ND, Hauser PJ, Lewis RE, Kontoyiannis DPmBioLive Monitoring and Analysis of Fungal Growth, Viability, and Mycelial Morphology Using the IncuCyte NeuroTrack Processing Module. mBio. 2019 05 28; 10(3).mBio2019-05-28T00:00:002019Live Monitoring and Analysis of Fungal Growth, Viability, and Mycelial Morphology Using the IncuCyte NeuroTrack Processing Module.31166627Szvalb AD, Kontoyiannis DPMycosesAcute acalculous cholecystitis due to Fusarium species and review of the literature on fungal cholecystitis. Mycoses. 2019 Sep; 62(9):847-853.Mycoses2019-07-01T00:00:002019Acute acalculous cholecystitis due to Fusarium species and review of the literature on fungal cholecystitis.Authorship 948803331174994Zhang H, Tan J, Kontoyiannis DP, Zhou Y, Liu W, Zhu P, Shi X, Wan Z, Li R, Liu WDiagnostic microbiology and infectious diseaseScreening the in vitro susceptibility of posaconazole in clinical isolates of Candida spp. and Aspergillus spp. and analyzing the sequence of ERG11 or CYP51A in non-wild-type isolates from China. Diagn Microbiol Infect Dis. 2019 Oct; 95(2):166-170.Diagn Microbiol Infect Dis2019-05-08T00:00:002019Screening the in vitro susceptibility of posaconazole in clinical isolates of Candida spp. and Aspergillus spp. and analyzing the sequence of ERG11 or CYP51A in non-wild-type isolates from China.Authorship 949707731225606Wurster S, Bandi A, Beyda ND, Albert ND, Raman NM, Raad II, Kontoyiannis DPThe Journal of antimicrobial chemotherapyDrosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris. J Antimicrob Chemother. 2019 07 01; 74(7):1904-1910.J Antimicrob Chemother2019-07-01T00:00:002019Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.Authorship 951185431277364Walsh TJ, Hospenthal DR, Petraitis V, Kontoyiannis DPJournal of fungi (Basel, Switzerland)Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma. J Fungi (Basel). 2019 Jul 04; 5(3).J Fungi (Basel)2019-07-04T00:00:002019Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma.Authorship 9521502Authorship 952238431254420Cornely OA, Hoenigl M, Lass-Fl?rl C, Chen SC, Kontoyiannis DP, Morrissey CO, Thompson GR, Mycoses Study Group Education and Research Consortium (MSG-ERC) and the European Confederation of MeMycosesDefining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology. Mycoses. 2019 Sep; 62(9):716-729.Mycoses2019-07-19T00:00:002019Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.31315952Wang Q, Kontoyiannis DP, Li R, Chen W, Bu D, Liu WJournal of clinical microbiologyA Novel Broad Allele-Specific TaqMan Real-Time PCR Method To Detect Triazole-Resistant Strains of Aspergillus fumigatus, Even with a Very Low Percentage of Triazole-Resistant Cells Mixed with Triazole-Susceptible Cells. J Clin Microbiol. 2019 09; 57(9).J Clin Microbiol2019-08-26T00:00:002019A Novel Broad Allele-Specific TaqMan Real-Time PCR Method To Detect Triazole-Resistant Strains of Aspergillus fumigatus, Even with a Very Low Percentage of Triazole-Resistant Cells Mixed with Triazole-Susceptible Cells.Authorship 9525052Authorship 952513531337723Casadevall A, Kontoyiannis DP, Robert VmBioOn the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds. mBio. 2019 07 23; 10(4).mBio2019-07-23T00:00:002019On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds.31338382Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DPOpen forum infectious diseasesOutcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study. Open Forum Infect Dis. 2019 Jul; 6(7):ofz247.Open Forum Infect Dis2019-07-19T00:00:002019Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study.Authorship 9541235Authorship 9542581331427139Lewis RE, Wurster S, Beyda ND, Albert ND, Kontoyiannis DPDiagnostic microbiology and infectious diseaseComparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis. Diagn Microbiol Infect Dis. 2019 Nov; 95(3):114861.Diagn Microbiol Infect Dis2019-07-05T00:00:002019Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.31436833Galloway-Pe?a JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, Daver NG, Alfayez M, Boddu PC, Khan MAW, Wargo JA, Do KA, Jenq RR, Kontoyiannis DP, Shelburne SAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaGut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia. Clin Infect Dis. 2020 06 24; 71(1):63-71.Clin Infect Dis2020-06-24T00:00:002020Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.Authorship 954868231481441Lamoth F, Kontoyiannis DPAntimicrobial agents and chemotherapyTherapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients. Antimicrob Agents Chemother. 2019 11; 63(11).Antimicrob Agents Chemother2019-10-22T00:00:002019Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.Authorship 9551163Authorship 955403131512518Kontoyiannis DPFuture microbiologyIs Candida auris here to stay? An interview with Dimitrios Kontoyiannis. Future Microbiol. 2019 09; 14:1083-1085.Future Microbiol2019-09-01T00:00:002019Is Candida auris here to stay? An interview with Dimitrios Kontoyiannis.31494023Abers MS, Lionakis MS, Kontoyiannis DPTrends in molecular medicineCheckpoint Inhibition and Infectious Diseases: A Good Thing? Trends Mol Med. 2019 12; 25(12):1080-1093.Trends Mol Med2019-09-04T00:00:002019Checkpoint Inhibition and Infectious Diseases: A Good Thing?Authorship 955626231527039Lewis RE, Kontoyiannis DP, Viale P, Sarpong EMAntimicrobial agents and chemotherapyUsing State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension. Antimicrob Agents Chemother. 2019 09 09; 63(12).Antimicrob Agents Chemother2019-09-09T00:00:002019Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension.80Professor. Chair, Department of Pharmacy Practice and Translational Research.true1Professor. Chair, Department of Pharmacy Practice and Translational Research.Professor. Chair, Department of Pharmacy Practice and Translational Research.Pharmacy Practice and Translational ResearchAuthorship 9580515Authorship 958238231674639Dipippo AJ, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaAzole-Associated Pseudohyperaldosteronism: A Class Effect or Azole-Specific? Clin Infect Dis. 2020 07 11; 71(2):467-468.Clin Infect Dis2020-07-11T00:00:002020Azole-Associated Pseudohyperaldosteronism: A Class Effect or Azole-Specific?31660349Kontoyiannis PD, Koons GL, Hicklen RS, Mikos AG, Kontoyiannis DPOpen forum infectious diseasesInsect Bite-Associated Invasive Fungal Infections. Open Forum Infect Dis. 2019 Oct; 6(10):ofz385.Open Forum Infect Dis2019-10-09T00:00:002019Insect Bite-Associated Invasive Fungal Infections.Authorship 960787531705917Malek AE, Taremi M, Spallone A, Alvarez-Cardona JJ, Kontoyiannis DPThe Journal of infectionNecrotizing soft tissue invasive aspergillosis in a cancer patient treated with immunosupressants due to checkpoint inhibitor-induced hepatitis. J Infect. 2020 02; 80(2):232-254.J Infect2019-11-06T00:00:002019Necrotizing soft tissue invasive aspergillosis in a cancer patient treated with immunosupressants due to checkpoint inhibitor-induced hepatitis.Authorship 961773531777755Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DPOpen forum infectious diseasesCorrigendum: Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study. Open Forum Infect Dis. 2019 Nov; 6(11):ofz458.Open Forum Infect Dis2019-11-25T00:00:002019Corrigendum: Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study.Authorship 9621272931802125Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PGClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaRevision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020 09 12; 71(6):1367-1376.Clin Infect Dis2020-09-12T00:00:002020Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.Authorship 975648231927567Lewis RE, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaChimeric Antigen Receptor T-cell Immunotherapy and Need for Prophylaxis for Invasive Mold Infections. Clin Infect Dis. 2020 10 23; 71(7):1802-1803.Clin Infect Dis2020-10-23T00:00:002020Chimeric Antigen Receptor T-cell Immunotherapy and Need for Prophylaxis for Invasive Mold Infections.Authorship 977222232006498Lewis RE, Kontoyiannis DPThe Lancet. Infectious diseasesInfectious disease consultation for candidaemia. Lancet Infect Dis. 2020 02; 20(2):164.Lancet Infect Dis2020-02-01T00:00:002020Infectious disease consultation for candidaemia.Authorship 9791922Authorship 979287532181546Koehler P, Denis B, Denning DW, Gangneux JP, Hoenigl M, Kontoyiannis DP, Krause R, Lagrou K, Lass-Fl?rl C, Maertens J, Marekovic I, Meis JF, Molina JM, Ple?ko S, Prattes J, Rath PM, Rautemaa-Richardson R, Richardson M, Segal E, Seidel D, Spriet I, Steinmann J, Verweij PE, Cornely OA, European Confederation of Medical Mycology (ECMM)MycosesEuropean confederation of medical mycology expert consult-An ECMM excellence center initiative. Mycoses. 2020 Jun; 63(6):566-572.Mycoses2020-04-13T00:00:002020European confederation of medical mycology expert consult-An ECMM excellence center initiative.32170948Fern?ndez-Cruz A, Lewis RE, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaHow Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions. Clin Infect Dis. 2020 07 27; 71(3):685-692.Clin Infect Dis2020-07-27T00:00:002020How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions.Authorship 98624923Authorship 986337132240277Galloway-Pe?a JR, Kontoyiannis DPPLoS pathogensThe gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions. PLoS Pathog. 2020 04; 16(4):e1008353.PLoS Pathog2020-04-02T00:00:002020The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions.32236406Bose P, McCue D, Wurster S, Wiederhold NP, Konopleva M, Kadia TM, Borthakur G, Ravandi F, Masarova L, Takahashi K, Estrov Z, Yilmaz M, Daver N, Pemmaraju N, Naqvi K, Rausch CR, Marx KR, Qiao W, Huang X, Bivins CA, Pierce SA, Kantarjian HM, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaIsavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study. Clin Infect Dis. 2021 05 18; 72(10):1755-1763.Clin Infect Dis2021-05-18T00:00:002021Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.Authorship 987428632295867Robinson S, Peterson CB, Sahasrabhojane P, Ajami NJ, Shelburne SA, Kontoyiannis DP, Galloway-Pe?a JRmSphereObservational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia. mSphere. 2020 04 15; 5(2).mSphere2020-04-15T00:00:002020Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia.Authorship 989442332407483Pappas PG, Boulware DR, Kontoyiannis DP, Miceli MH, Ostrosky-Zeichner L, Spec A, Thompson GR, Chen S, Perfect JR, MSGERC investigatorsMedical mycologyClinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agenda. Med Mycol. 2020 07 01; 58(5):569-578.Med Mycol2020-07-01T00:00:002020Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agenda.Authorship 989771932432714Wurster S, Robinson P, Albert ND, Tarrand JJ, Goff M, Swamydas M, Lim JK, Lionakis MS, Kontoyiannis DPThe Journal of infectious diseasesProtective Activity of Programmed Cell Death Protein 1 Blockade and Synergy With Caspofungin in a Murine Invasive Pulmonary Aspergillosis Model. J Infect Dis. 2020 08 17; 222(6):989-994.J Infect Dis2020-08-17T00:00:002020Protective Activity of Programmed Cell Death Protein 1 Blockade and Synergy With Caspofungin in a Murine Invasive Pulmonary Aspergillosis Model.Authorship 990278332458510Anastasopoulou A, DiPippo AJ, Kontoyiannis DPMycosesNon-Aspergillus invasive mould infections in patients treated with ibrutinib. Mycoses. 2020 Aug; 63(8):787-793.Mycoses2020-06-19T00:00:002020Non-Aspergillus invasive mould infections in patients treated with ibrutinib.Authorship 990776632477858Yang X, Shi X, Chen W, Zhou Y, Lionakis MS, Kontoyiannis DP, Liu WMedical mycology case reportsFirst report of kerion (tinea capitis) caused by combined Trichophyton mentagrophytes and Microsporum canis. Med Mycol Case Rep. 2020 Sep; 29:5-7.Med Mycol Case Rep2020-05-19T00:00:002020First report of kerion (tinea capitis) caused by combined Trichophyton mentagrophytes and Microsporum canis.Authorship 991617632530347Frei M, Aitken SL, Jain N, Thompson P, Wierda W, Kontoyiannis DP, DiPippo AJLeukemia & lymphomaIncidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib. Leuk Lymphoma. 2020 10; 61(10):2488-2491.Leuk Lymphoma2020-06-12T00:00:002020Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib.Authorship 9919923Authorship 992408732544947Aitken SL, Sahasrabhojane PV, Kontoyiannis DP, Savidge TC, Arias CA, Ajami NJ, Shelburne SA, Galloway-Pe?a JRClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaAlterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy. Clin Infect Dis. 2021 05 04; 72(9):1507-1513.Clin Infect Dis2021-05-04T00:00:002021Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy.32564081Malek AE, Khalil M, Hachem R, Chaftari AM, Fares J, Jiang Y, Kontoyiannis DP, Fossella F, Chaftari P, Mulanovich VE, Viola GM, Raad IIClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaImpact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis. 2021 11 02; 73(9):e2697-e2704.Clin Infect Dis2021-11-02T00:00:002021Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study.Authorship 9930019Authorship 9930891232602954Abudayyeh A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Martinez CS, Page VD, Tarrand JJ, Kontoyiannis DP, Marin D, Oran B, Olson A, Jones R, Popat U, Champlin RE, Chemaly RF, Shpall EJ, Rezvani KTransplant infectious disease : an official journal of the Transplantation SocietyDevelopment and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2020 Oct; 22(5):e13395.Transpl Infect Dis2020-07-14T00:00:002020Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients.32605990Wurster S, Tatara AM, Albert ND, Ibrahim AS, Heitman J, Lee SC, Shetty AC, McCracken C, Graf KT, Mikos AG, Bruno VM, Kontoyiannis DPmBioTornadic Shear Stress Induces a Transient, Calcineurin-Dependent Hypervirulent Phenotype in Mucorales Molds. mBio. 2020 06 30; 11(3).mBio2020-06-30T00:00:002020Tornadic Shear Stress Induces a Transient, Calcineurin-Dependent Hypervirulent Phenotype in Mucorales Molds.Authorship 993988632650108Szvalb AD, Malek AE, Jiang Y, Bhatti MM, Wurster S, Kontoyiannis DPThe Journal of infectionSerum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR. J Infect. 2020 09; 81(3):443-451.J Infect2020-07-07T00:00:002020Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR.Authorship 994599432678869Wurster S, Lyos S, Albert ND, Kontoyiannis DPMedical mycologyPharmacological serum concentrations of epinephrine and norepinephrine do not affect growth rate, morphogenesis, stress tolerance, and virulence of Candida albicans. Med Mycol. 2021 Jan 04; 59(1):102-105.Med Mycol2021-01-04T00:00:002021Pharmacological serum concentrations of epinephrine and norepinephrine do not affect growth rate, morphogenesis, stress tolerance, and virulence of Candida albicans.Authorship 995147332704512Spallone A, Hicklen RS, Kontoyiannis DPOpen forum infectious diseasesInvasive Fungal Infections at Presentation of Untreated Hematologic Malignancies: Rare and Elusive. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa247.Open Forum Infect Dis2020-07-18T00:00:002020Invasive Fungal Infections at Presentation of Untreated Hematologic Malignancies: Rare and Elusive.Authorship 9961651232756879Johnson MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, Zaoutis T, Thompson GR, Andes DR, Walsh TJ, Pappas PG, Cornely OA, Perfect JR, Kontoyiannis DPThe Journal of infectious diseasesCore Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium. J Infect Dis. 2020 08 05; 222(Suppl 3):S175-S198.J Infect Dis2020-08-05T00:00:002020Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium.Authorship 996821332780498P?rez-Jacoiste As?n MA, L?pez-Medrano F, Fern?ndez-Ruiz M, Silva JT, San Juan R, Kontoyiannis DP, Aguado JMAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsRisk factors for the development of invasive aspergillosis after kidney transplantation: Systematic review and meta-analysis. Am J Transplant. 2021 02; 21(2):703-716.Am J Transplant2020-09-04T00:00:002020Risk factors for the development of invasive aspergillosis after kidney transplantation: Systematic review and meta-analysis.Authorship 999334732914014Abou Dalle I, Bannon SA, Patel KP, Routbort MJ, Cortes JE, Ferrajoli A, Kontoyiannis DP, Wang SA, DiNardo CDJCO precision oncologyGermline Genetic Predisposition to Myeloid Neoplasia From GATA2 Gene Mutations: Lessons Learned From Two Cases. JCO Precis Oncol. 2019; 3.JCO Precis Oncol2019-03-04T00:00:002019Germline Genetic Predisposition to Myeloid Neoplasia From GATA2 Gene Mutations: Lessons Learned From Two Cases.Authorship 1002131633017225Wurster S, Sass G, Albert ND, Nazik H, D?ziel E, Stevens DA, Kontoyiannis DPVirulenceLive imaging and quantitative analysis of Aspergillus fumigatus growth and morphology during inter-microbial interaction with Pseudomonas aeruginosa. Virulence. 2020 12; 11(1):1329-1336.Virulence2020-12-01T00:00:002020Live imaging and quantitative analysis of Aspergillus fumigatus growth and morphology during inter-microbial interaction with Pseudomonas aeruginosa.Authorship 1004502133150364Colombo AL, Agnelli C, Kontoyiannis DPThe Journal of antimicrobial chemotherapyKnowledge gaps in candidaemia/invasive candidiasis in haematological cancer patients. J Antimicrob Chemother. 2021 02 11; 76(3):543-546.J Antimicrob Chemother2021-02-11T00:00:002021Knowledge gaps in candidaemia/invasive candidiasis in haematological cancer patients.Authorship 1006689233301030Puerta-Alcalde P, Champlin RE, Kontoyiannis DPBloodHow I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease. Blood. 2020 12 10; 136(24):2741-2753.Blood2020-12-10T00:00:002020How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.Authorship 10081933Authorship 1008402233396870Lamoth F, Lewis RE, Kontoyiannis DPJournal of fungi (Basel, Switzerland)Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections. J Fungi (Basel). 2020 Dec 30; 7(1).J Fungi (Basel)2020-12-30T00:00:002020Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections.33413823Malek AE, Kontoyiannis DPMayo Clinic proceedingsSuperficial Thrombophlebitis From Intravenous Pentamidine in Hematopoietic Cell Transplantation Recipient. Mayo Clin Proc. 2021 01; 96(1):257-258.Mayo Clin Proc2021-01-01T00:00:002021Superficial Thrombophlebitis From Intravenous Pentamidine in Hematopoietic Cell Transplantation Recipient.Authorship 10092848Authorship 1009466333476401Viola GM, Malek AE, Rosen LB, DiNardo AR, Nishiguchi T, Okhuysen PC, Holland SM, Kontoyiannis DPMycosesDisseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: An underappreciated association. Mycoses. 2021 Jun; 64(6):576-582.Mycoses2021-02-05T00:00:002021Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: An underappreciated association.33460558Gudiol C, Lewis RE, Strati P, Kontoyiannis DPThe Lancet. HaematologyChimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection? Lancet Haematol. 2021 Mar; 8(3):e216-e228.Lancet Haematol2021-01-15T00:00:002021Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?Authorship 1009984333501958Chamilos G, Lionakis MS, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaAre All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)? Clin Infect Dis. 2021 01 27; 72(2):351-356.Clin Infect Dis2021-01-27T00:00:002021Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?Authorship 1010872433552049Kim ST, Sheshadri A, Shannon V, Kontoyiannis DP, Kantarjian H, Garcia-Manero G, Ravandi F, Im JS, Boddu P, Bashoura L, Balachandran DD, Evans SE, Faiz S, Ruiz Vazquez W, Divenko M, Mathur R, Tippen SP, Gumbs C, Neelapu SS, Naing A, Wang L, Diab A, Futreal A, Nurieva R, Daver NFrontiers in immunologyDistinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications. Front Immunol. 2020; 11:590494.Front Immunol2021-01-21T00:00:002021Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications.Authorship 1012219233621531Sassine J, Kontoyiannis DPThe American journal of medicineA 77-Year-Old Man with Multiple Myeloma and a Lytic Bone Lesion. Am J Med. 2021 07; 134(7):860-862.Am J Med2021-02-21T00:00:002021A 77-Year-Old Man with Multiple Myeloma and a Lytic Bone Lesion.Authorship 1013620533709128Lockhart SR, Bialek R, Kibbler CC, Cuenca-Estrella M, Jensen HE, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaMolecular Techniques for Genus and Species Determination of Fungi From Fresh and Paraffin-Embedded Formalin-Fixed Tissue in the Revised EORTC/MSGERC Definitions of Invasive Fungal Infection. Clin Infect Dis. 2021 03 12; 72(Suppl 2):S109-S113.Clin Infect Dis2021-03-12T00:00:002021Molecular Techniques for Genus and Species Determination of Fungi From Fresh and Paraffin-Embedded Formalin-Fixed Tissue in the Revised EORTC/MSGERC Definitions of Invasive Fungal Infection.Authorship 1013904233727350Casadevall A, Kontoyiannis DP, Robert VmBioEnvironmental Candida auris and the Global Warming Emergence Hypothesis. mBio. 2021 03 16; 12(2).mBio2021-03-16T00:00:002021Environmental Candida auris and the Global Warming Emergence Hypothesis.Authorship 10144879Authorship 1014596433761358Wurster S, Ruiz OE, Samms KM, Tatara AM, Albert ND, Kahan PH, Nguyen AT, Mikos AG, Kontoyiannis DP, Eisenhoffer GTCell reportsEGF-mediated suppression of cell extrusion during mucosal damage attenuates opportunistic fungal invasion. Cell Rep. 2021 03 23; 34(12):108896.Cell Rep2021-03-23T00:00:002021EGF-mediated suppression of cell extrusion during mucosal damage attenuates opportunistic fungal invasion.33770176Lamoth F, Lewis RE, Walsh TJ, Kontoyiannis DPThe Journal of infectious diseasesNavigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis. J Infect Dis. 2021 11 22; 224(10):1631-1640.J Infect Dis2021-11-22T00:00:002021Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.Authorship 10150795Authorship 101567821Authorship 1015781833822103Johnson MD, Lewis RE, Dodds Ashley ES, Perfect JR, Kontoyiannis DPThe Journal of infectious diseasesReply to Day et al. J Infect Dis. 2021 11 16; 224(9):1627-1628.J Infect Dis2021-11-16T00:00:002021Reply to Day et al.33793970Rausch CR, DiNardo CD, Maiti A, Jammal NJ, Kadia TM, Marx KR, Borthakur G, Savoy JM, Pemmaraju N, DiPippo AJ, Daver NG, Chew SM, Sasaki K, Issa GC, Short NJ, Takahashi K, Ohanian MN, Ning J, Xiao L, Alvarado Y, Kontoyiannis DP, Ravandi F, Kantarjian HM, Konopleva MYCancerDuration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia. Cancer. 2021 07 15; 127(14):2489-2499.Cancer2021-04-01T00:00:002021Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia.33802827Axell-House DB, Wurster S, Jiang Y, Kyvernitakis A, Lewis RE, Tarrand JJ, Raad II, Kontoyiannis DPJournal of fungi (Basel, Switzerland)Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer. J Fungi (Basel). 2021 Mar 17; 7(3).J Fungi (Basel)2021-03-17T00:00:002021Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer.Authorship 1018998234016279Ben-Ami R, Kontoyiannis DPInfectious disease clinics of North AmericaResistance to Antifungal Drugs. Infect Dis Clin North Am. 2021 06; 35(2):279-311.Infect Dis Clin North Am2021-06-01T00:00:002021Resistance to Antifungal Drugs.Authorship 1019192234022008John TM, Kontoyiannis DPChestDo Not Forget Daptomycin as a Cause of Eosinophilic Pneumonia! Chest. 2021 04; 159(4):1687-1688.Chest2021-04-06T00:00:002021Do Not Forget Daptomycin as a Cause of Eosinophilic Pneumonia!Authorship 10241882Authorship 1024201434190571Lass-Fl?rl C, Dietl AM, Kontoyiannis DP, Brock MClinical microbiology reviewsAspergillus terreus Species Complex. Clin Microbiol Rev. 2021 12 15; 34(4):e0031120.Clin Microbiol Rev2021-06-30T00:00:002021Aspergillus terreus Species Complex.34192575Fekkar A, Neofytos D, Nguyen MH, Clancy CJ, Kontoyiannis DP, Lamoth FClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious DiseasesCOVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? Clin Microbiol Infect. 2021 09; 27(9):1376-1378.Clin Microbiol Infect2021-06-27T00:00:002021COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?Authorship 1030621434570643DiPippo AJ, McDaneld PM, Tverdek FP, Kontoyiannis DPAntimicrobial agents and chemotherapyEffect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy. Antimicrob Agents Chemother. 2021 11 17; 65(12):e0123021.Antimicrob Agents Chemother2021-09-27T00:00:002021Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy.Authorship 10332195Authorship 1033869234751181Rossato L, Carlesse F, Nobrega de Almeida J, Kontoyiannis DP, Colombo ALCurrent opinion in infectious diseasesHow different is invasive fusariosis in pediatric patients than in adults? A systematic review. Curr Opin Infect Dis. 2021 12 01; 34(6):619-626.Curr Opin Infect Dis2021-12-01T00:00:002021How different is invasive fusariosis in pediatric patients than in adults? A systematic review.34810120Spallone A, Alotaibi AS, Jiang Y, Daver N, Kontoyiannis DPClinical lymphoma, myeloma & leukemiaInfectious Complications Among Patients With AML Treated With Immune Checkpoint Inhibitors. Clin Lymphoma Myeloma Leuk. 2022 05; 22(5):305-310.Clin Lymphoma Myeloma Leuk2021-10-29T00:00:002021Infectious Complications Among Patients With AML Treated With Immune Checkpoint Inhibitors.Authorship 1034839434849488Wurster S, Ruiz OE, Tatara AM, Kontoyiannis DP, Eisenhoffer GTSTAR protocolsProtocol for fungal infection following the induction of epithelial cell loss in larval zebrafish. STAR Protoc. 2021 12 17; 2(4):100963.STAR Protoc2021-11-19T00:00:002021Protocol for fungal infection following the induction of epithelial cell loss in larval zebrafish.Authorship 10351891334888961Thompson GR, Garcia-Diaz J, Miceli MH, Nguyen MH, Ostrosky-Zeichner L, Young JH, Fisher CE, Clark NM, Greenberg RN, Spec A, Kovanda L, Croos-Dabrera R, Kontoyiannis DPMycosesSystemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study. Mycoses. 2022 Feb; 65(2):186-198.Mycoses2021-12-22T00:00:002021Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study.Authorship 1035744434926712Dhal U, Hicklen RS, Tarrand J, Kontoyiannis DPOpen forum infectious diseasesCat Scratch Disease as a Mimicker of Malignancy. Open Forum Infect Dis. 2021 Nov; 8(11):ofab500.Open Forum Infect Dis2021-10-05T00:00:002021Cat Scratch Disease as a Mimicker of Malignancy.Authorship 1036603334986246Lamoth F, Lewis RE, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaInvestigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective. Clin Infect Dis. 2022 08 31; 75(3):534-544.Clin Infect Dis2022-08-31T00:00:002022Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective.Authorship 10383179Authorship 10387759Authorship 10392554Authorship 10412013Authorship 10415207Authorship 1041744435224979Wurster S, Albert ND, Kontoyiannis DPmSphereCandida auris Bloodstream Infection Induces Upregulation of the PD-1/PD-L1 Immune Checkpoint Pathway in an Immunocompetent Mouse Model. mSphere. 2022 04 27; 7(2):e0081721.mSphere2022-02-28T00:00:002022Candida auris Bloodstream Infection Induces Upregulation of the PD-1/PD-L1 Immune Checkpoint Pathway in an Immunocompetent Mouse Model.35107318Hu C, Fong G, Wurster S, Kontoyiannis DP, Beyda NDMicrobiology spectrumClumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrata. Microbiol Spectr. 2022 02 23; 10(1):e0183721.Microbiol Spectr2022-02-02T00:00:002022Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrata.35288118Wurster S, Paraskevopoulos T, Toda M, Jiang Y, Tarrand JJ, Williams S, Chiller TM, Jackson BR, Kontoyiannis DPThe Journal of infectionInvasive mould infections in patients from floodwater-damaged areas after hurricane Harvey - a closer look at an immunocompromised cancer patient population. J Infect. 2022 05; 84(5):701-709.J Infect2022-03-12T00:00:002022Invasive mould infections in patients from floodwater-damaged areas after hurricane Harvey - a closer look at an immunocompromised cancer patient population.35357212Skaria J, John TM, Varkey S, Kontoyiannis DPmBioAre Unique Regional Factors the Missing Link in India's COVID-19-Associated Mucormycosis Crisis? mBio. 2022 04 26; 13(2):e0047322.mBio2022-03-31T00:00:002022Are Unique Regional Factors the Missing Link in India's COVID-19-Associated Mucormycosis Crisis?35251033Wurster S, Albert ND, Bharadwaj U, Kasembeli MM, Tarrand JJ, Daver N, Kontoyiannis DPFrontiers in immunologyBlockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis. Front Immunol. 2022; 13:838344.Front Immunol2022-02-18T00:00:002022Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis.35325094Rausch CR, DiPippo AJ, Jiang Y, DiNardo CD, Kadia T, Maiti A, Montalban-Bravo G, Ravandi F, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaComparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies. Clin Infect Dis. 2022 Oct 29; 75(9):1503-1510.Clin Infect Dis2022-10-29T00:00:002022Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.Authorship 10440399Authorship 10442745Authorship 10443222635433514Franklin S, Aitken SL, Shi Y, Sahasrabhojane PV, Robinson S, Peterson CB, Daver N, Ajami NA, Kontoyiannis DP, Shelburne SA, Galloway-Pe?a JFrontiers in cellular and infection microbiologyOral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients. Front Cell Infect Microbiol. 2022; 12:848580.Front Cell Infect Microbiol2022-03-31T00:00:002022Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients.35448611Spallone A, Moran CA, Wurster S, Axell-House DB, Kontoyiannis DPJournal of fungi (Basel, Switzerland)Taking a Closer Look: Clinical and Histopathological Characteristics of Culture-Positive versus Culture-Negative Pulmonary Mucormycosis. J Fungi (Basel). 2022 Apr 08; 8(4).J Fungi (Basel)2022-04-08T00:00:002022Taking a Closer Look: Clinical and Histopathological Characteristics of Culture-Positive versus Culture-Negative Pulmonary Mucormycosis.35452134Sheshadri A, Goizueta AA, Shannon VR, London D, Garcia-Manero G, Kantarjian HM, Ravandi-Kashani F, Kadia TM, Konopleva MY, DiNardo CD, Pierce S, Zarifa A, Albittar AA, Zhong LL, Akhmedzhanov FO, Arain MH, Alfayez M, Alotaibi A, Altan M, Naing A, Mendoza TR, Godoy MCB, Shroff G, Kim ST, Faiz SA, Kontoyiannis DP, Khawaja F, Jennings K, Daver NGCancerPneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study. Cancer. 2022 07 15; 128(14):2736-2745.Cancer2022-04-22T00:00:002022Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study.23905713Lewis RE, Georgiadou SP, Sampsonas F, Chamilos G, Kontoyiannis DPMycosesRisk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis. Mycoses. 2014 Jan; 57(1):49-55.Mycoses2013-06-12T00:00:002013Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis.24145540Dimopoulou D, Hamilos G, Tzardi M, Lewis RE, Samonis G, Kontoyiannis DPAntimicrobial agents and chemotherapyAnidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibility. Antimicrob Agents Chemother. 2014; 58(1):229-36.Antimicrob Agents Chemother2013-10-21T00:00:002013Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibility.24309535Kontoyiannis DPBest practice & research. Clinical haematologyRational approach to pulmonary infiltrates in leukemia and transplantation. Best Pract Res Clin Haematol. 2013 Sep; 26(3):301-6.Best Pract Res Clin Haematol2013-10-16T00:00:002013Rational approach to pulmonary infiltrates in leukemia and transplantation.Authorship 10465541535611348Thompson GR, Boulware DR, Bahr NC, Clancy CJ, Harrison TS, Kauffman CA, Le T, Miceli MH, Mylonakis E, Nguyen MH, Ostrosky-Zeichner L, Patterson TF, Perfect JR, Spec A, Kontoyiannis DP, Pappas PGOpen forum infectious diseasesNoninvasive Testing and Surrogate Markers in Invasive Fungal Diseases. Open Forum Infect Dis. 2022 Jun; 9(6):ofac112.Open Forum Infect Dis2022-03-04T00:00:002022Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases.Authorship 1047777335674964Wurster S, Albert ND, Kontoyiannis DPMethods in molecular biology (Clifton, N.J.)Drosophila melanogaster as a Rapid and Reliable In Vivo Infection Model to Study the Emerging Yeast Pathogen Candida auris. Methods Mol Biol. 2022; 2517:299-316.Methods Mol Biol2022-01-01T00:00:002022Drosophila melanogaster as a Rapid and Reliable In Vivo Infection Model to Study the Emerging Yeast Pathogen Candida auris.Authorship 1050834735856665Harish E, Sarkar A, Handelman M, Abo Kandil A, Shadkchan Y, Wurster S, Kontoyiannis DP, Osherov NAntimicrobial agents and chemotherapyTriazole Priming as an Adaptive Response and Gateway to Resistance in Aspergillus fumigatus. Antimicrob Agents Chemother. 2022 08 16; 66(8):e0045822.Antimicrob Agents Chemother2022-07-20T00:00:002022Triazole Priming as an Adaptive Response and Gateway to Resistance in Aspergillus fumigatus.Authorship 10562775Authorship 10586338Authorship 105782650Authorship 10560734Authorship 10613781Authorship 105919410Authorship 10603055Authorship 10592305Authorship 1058973336389687Wurster S, Watowich SS, Kontoyiannis DPFrontiers in immunologyCheckpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions. Front Immunol. 2022; 13:1018202.Front Immunol2022-10-25T00:00:002022Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions.36049031Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaStatin Use and Aspergillosis Risk-More than Meets the Eye? Clin Infect Dis. 2023 01 13; 76(2):368.Clin Infect Dis2023-01-13T00:00:002023Statin Use and Aspergillosis Risk-More than Meets the Eye?36675866Franklin A, Wurster S, Axell-House DB, Jiang Y, Kontoyiannis DPJournal of fungi (Basel, Switzerland)Impact of Hyperglycemia and Diabetes Mellitus on Breakthrough Mucormycosis Outcomes in Patients with Hematologic Malignancies-Complex and Intriguing Associations. J Fungi (Basel). 2022 Dec 28; 9(1).J Fungi (Basel)2022-12-28T00:00:002022Impact of Hyperglycemia and Diabetes Mellitus on Breakthrough Mucormycosis Outcomes in Patients with Hematologic Malignancies-Complex and Intriguing Associations.36611269Wurster S, Pantale?n Garc?a J, Albert ND, Jiang Y, Bhoda K, Kulkarni VV, Wang Y, Walsh TJ, Evans S, Kontoyiannis DPThe Journal of infectious diseasesDevelopment of a Corticosteroid-Immunosuppressed Mouse Model to Study the Pathogenesis and Therapy of Influenza-Associated Pulmonary Aspergillosis. J Infect Dis. 2023 04 12; 227(7):901-906.J Infect Dis2023-04-12T00:00:002023Development of a Corticosteroid-Immunosuppressed Mouse Model to Study the Pathogenesis and Therapy of Influenza-Associated Pulmonary Aspergillosis.36097568Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Cruz AF, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragivich T, Kiat YEV, Fakhreddine S, Hanna PA, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Guevara EY, Torres H, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, Garc?a-Garc?a ?, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Kontoyiannis DP, Malek AE, Chaftari AMmedRxiv : the preprint server for health sciencesInternational Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv. 2022 Aug 26.medRxiv2022-08-26T00:00:002022International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship.36448782Gamaletsou MN, Rammaert B, Brause B, Bueno MA, Dadwal SS, Henry MW, Katragkou A, Kontoyiannis DP, McCarthy MW, Miller AO, Moriyama B, Pana ZD, Petraitiene R, Petraitis V, Roilides E, Sarkis JP, Simitsopoulou M, Sipsas NV, Taj-Aldeen SJ, Zeller V, Lortholary O, Walsh TJ, International Consortium for Osteoarticular MycosesClinical microbiology reviewsOsteoarticular Mycoses. Clin Microbiol Rev. 2022 12 21; 35(4):e0008619.Clin Microbiol Rev2022-11-30T00:00:002022Osteoarticular Mycoses.36059133Colombo AL, De Almeida JN, Lewis RE, Kontoyiannis DPThe Journal of antimicrobial chemotherapyQuandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis. J Antimicrob Chemother. 2022 10 28; 77(11):2897-2900.J Antimicrob Chemother2022-10-28T00:00:002022Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis.36686636Szvalb AD, Yepez Guevara E, Euscher E, Nahmod KA, Kontoyiannis DPOpen forum infectious diseasesAcute Peritoneal Histoplasmosis Mimicking Ovarian Cancer and Review of the Literature on Histoplasma Peritonitis. Open Forum Infect Dis. 2023 Jan; 10(1):ofac705.Open Forum Infect Dis2023-01-10T00:00:002023Acute Peritoneal Histoplasmosis Mimicking Ovarian Cancer and Review of the Literature on Histoplasma Peritonitis.36154180Stafylaki D, Maraki S, Vaporidi K, Georgopoulos D, Kontoyiannis DP, Kofteridis DP, Chamilos GMicrobiology spectrumImpact of Molecular Syndromic Diagnosis of Severe Pneumonia in the Management of Critically Ill Patients. Microbiol Spectr. 2022 10 26; 10(5):e0161622.Microbiol Spectr2022-09-26T00:00:002022Impact of Molecular Syndromic Diagnosis of Severe Pneumonia in the Management of Critically Ill Patients.36715684Raad II, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Fern?ndez Cruz A, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragovich T, Vong Kiat YE, Fakhreddine S, Pierre AH, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Yepez EY, Torres HA, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, Garc?a AG, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Kontoyiannis DP, Malek AE, Chaftari AMeLifeInternational multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.Elife2023-01-30T00:00:002023International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship.Authorship 1063937736790120Chowdhary A, Gupta N, Wurster S, Kumar R, Mohabir JT, Tatavarthy S, Mittal V, Rani P, Barman P, Sachdeva N, Singh A, Sharma B, Jiang Y, Cuomo CA, Kontoyiannis DPMycosesMultimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors. Mycoses. 2023 Jun; 66(6):515-526.Mycoses2023-02-27T00:00:002023Multimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors.Authorship 106463051Authorship 10658871136910694Toda M, Williams S, Jackson BR, Wurster S, Serpa JA, Nigo M, Grimes CZ, Atmar RL, Chiller TM, Ostrosky-Zeichner L, Kontoyiannis DPOpen forum infectious diseasesInvasive Mold Infections Following Hurricane Harvey-Houston, Texas. Open Forum Infect Dis. 2023 Mar; 10(3):ofad093.Open Forum Infect Dis2023-02-21T00:00:002023Invasive Mold Infections Following Hurricane Harvey-Houston, Texas.Authorship 1067848337108918Vuong NN, Hammond D, Kontoyiannis DPJournal of fungi (Basel, Switzerland)Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges. J Fungi (Basel). 2023 Apr 12; 9(4).J Fungi (Basel)2023-04-12T00:00:002023Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges.Authorship 1070581337187499Babakhanlou R, Ravandi-Kashani F, Kontoyiannis DPJournal of hematologyNeutropenic Enterocolitis: An Uncommon, but Fearsome Complication of Leukemia. J Hematol. 2023 Apr; 12(2):59-65.J Hematol2023-04-30T00:00:002023Neutropenic Enterocolitis: An Uncommon, but Fearsome Complication of Leukemia.Authorship 1075793237504732Lynch JP, Kontoyiannis DPJournal of fungi (Basel, Switzerland)Special Issue "Diagnosis and Treatment of Invasive Pulmonary Fungal Infections". J Fungi (Basel). 2023 Jul 13; 9(7).J Fungi (Basel)2023-07-13T00:00:002023Special Issue "Diagnosis and Treatment of Invasive Pulmonary Fungal Infections".Authorship 10791648Authorship 1077909237550272Chiu CY, Matsuo T, Wurster S, Gerstein Y, Hammond DE, Chien KS, DiNardo C, Kontoyiannis DPMycosesInvasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency. Mycoses. 2023 Dec; 66(12):1029-1034.Mycoses2023-08-07T00:00:002023Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency.37732771Dailey Garnes NJM, Kontoyiannis DPCurrent opinion in infectious diseasesMucormycosis: update on clinical presentation, diagnosis, and treatment. Curr Opin Infect Dis. 2023 12 01; 36(6):427-435.Curr Opin Infect Dis2023-09-21T00:00:002023Mucormycosis: update on clinical presentation, diagnosis, and treatment.Authorship 1081137237808914Alqarihi A, Kontoyiannis DP, Ibrahim ASFrontiers in cellular and infection microbiologyMucormycosis in 2023: an update on pathogenesis and management. Front Cell Infect Microbiol. 2023; 13:1254919.Front Cell Infect Microbiol2023-09-21T00:00:002023Mucormycosis in 2023: an update on pathogenesis and management.Authorship 10815702037841255Aminu M, Daver N, Godoy MCB, Shroff G, Wu C, Torre-Sada LF, Goizueta A, Shannon VR, Faiz SA, Altan M, Garcia-Manero G, Kantarjian H, Ravandi-Kashani F, Kadia T, Konopleva M, DiNardo C, Pierce S, Naing A, Kim ST, Kontoyiannis DP, Khawaja F, Chung C, Wu J, Sheshadri AFrontiers in immunologyHeterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept. Front Immunol. 2023; 14:1249511.Front Immunol2023-09-29T00:00:002023Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept.Authorship 10841912Authorship 10845581237967456Adachi JA, Kontoyiannis DPGastroenterology & hepatologyGastrointestinal Mucormycosis: An Elusive, Unusual, and Severe Opportunistic Mycosis. Gastroenterol Hepatol (N Y). 2009 Sep; 5(9):661-662.Gastroenterol Hepatol (N Y)2009-09-01T00:00:002009Gastrointestinal Mucormycosis: An Elusive, Unusual, and Severe Opportunistic Mycosis.38053535Jenks JD, Prattes J, Wurster S, Sprute R, Seidel D, Oliverio M, Egger M, Del Rio C, Sati H, Cornely OA, Thompson GR, Kontoyiannis DP, Hoenigl MEClinicalMedicineSocial determinants of health as drivers of fungal disease. EClinicalMedicine. 2023 Dec; 66:102325.EClinicalMedicine2023-11-18T00:00:002023Social determinants of health as drivers of fungal disease.Authorship 1085181738073151Matsuo T, Wurster S, Jiang Y, Sasaki K, Tarrand J, Lewis RE, Kontoyiannis DPThe Journal of antimicrobial chemotherapyInvasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes. J Antimicrob Chemother. 2024 Feb 01; 79(2):297-306.J Antimicrob Chemother2024-02-01T00:00:002024Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes.Authorship 1086206338173423Matsuo T, Wurster S, Kontoyiannis DPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaGood Outcomes in Salvage Therapy of Fusariosis in Patients With Leukemia: Is It the Host or the Drug? Clin Infect Dis. 2024 Jan 04.Clin Infect Dis2024-01-04T00:00:002024Good Outcomes in Salvage Therapy of Fusariosis in Patients With Leukemia: Is It the Host or the Drug?Authorship 1087603738248950Egge SL, Wurster S, Cho SY, Jiang Y, Axell-House DB, Miller WR, Kontoyiannis DPJournal of fungi (Basel, Switzerland)Co-Occurrence of Gram-Negative Rods in Patients with Hematologic Malignancy and Sinopulmonary Mucormycosis. J Fungi (Basel). 2024 Jan 04; 10(1).J Fungi (Basel)2024-01-04T00:00:002024Co-Occurrence of Gram-Negative Rods in Patients with Hematologic Malignancy and Sinopulmonary Mucormycosis.Authorship 1088792338340331Dinh A, Savoy JM, Kontoyiannis DP, Takahashi K, Issa GC, Kantarjian HM, DiNardo CD, Rausch CRCancerIvosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer. 2024 Feb 10.Cancer2024-02-10T00:00:002024Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome.Authorship 1089205538379571Matsuo T, Wurster S, Jiang Y, Tarrand J, Kontoyiannis DPOpen forum infectious diseasesAdjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordance Between Responses of Skin Lesions and Systemic Outcomes. Open Forum Infect Dis. 2024 Feb; 11(2):ofae068.Open Forum Infect Dis2024-02-13T00:00:002024Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordance Between Responses of Skin Lesions and Systemic Outcomes.Authorship 10897821038415653Kumaresan PR, Wurster S, Bavisi K, da Silva TA, Hauser P, Kinnitt J, Albert ND, Bharadwaj U, Neelapu S, Kontoyiannis DPmBioA novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus. mBio. 2024 Feb 28; e0341323.mBio2024-02-28T00:00:002024A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus.Authorship 10912722Authorship 10912231438518791Seidel D, Wurster S, Jenks JD, Sati H, Gangneux JP, Egger M, Alastruey-Izquierdo A, Ford NP, Chowdhary A, Sprute R, Cornely O, Thompson GR, Hoenigl M, Kontoyiannis DPThe Lancet. MicrobeImpact of climate change and natural disasters on fungal infections. Lancet Microbe. 2024 Mar 19.Lancet Microbe2024-03-19T00:00:002024Impact of climate change and natural disasters on fungal infections.38501431Lamoth F, Kontoyiannis DPExpert review of molecular diagnosticsPCR diagnostic platforms for non-Aspergillus mold infections: ready for routine implementation in the clinic? Expert Rev Mol Diagn. 2024 Mar 19; 1-10.Expert Rev Mol Diagn2024-03-19T00:00:002024PCR diagnostic platforms for non-Aspergillus mold infections: ready for routine implementation in the clinic?true1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor23799666Kontoyiannis DPVirulenceVirulence profile: Dimitrios P Kontoyiannis. Virulence. 2013 Jul 01; 4(5):429-31.Virulence2013-07-01T00:00:002013Virulence profile: Dimitrios P Kontoyiannis.24147728Kontoyiannis DP, Azie N, Franks B, Horn DLMycosesProspective antifungal therapy (PATH) alliance(?) : focus on mucormycosis. Mycoses. 2014 Apr; 57(4):240-6.Mycoses2013-10-22T00:00:002013Prospective antifungal therapy (PATH) alliance(?) : focus on mucormycosis.24277033Gomes MZ, Mulanovich VE, Jiang Y, Lewis RE, Kontoyiannis DPAntimicrobial agents and chemotherapyIncidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011. Antimicrob Agents Chemother. 2014; 58(2):865-73.Antimicrob Agents Chemother2013-11-25T00:00:002013Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.24378282Gamaletsou MN, Rammaert B, Bueno MA, Moriyama B, Sipsas NV, Kontoyiannis DP, Roilides E, Zeller V, Prinapori R, Taj-Aldeen SJ, Brause B, Lortholary O, Walsh TJThe Journal of infectionAspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome. J Infect. 2014 May; 68(5):478-93.J Infect2013-12-27T00:00:002013Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome.24395226Lewis RE, Liao G, Young K, Douglas C, Kontoyiannis DPAntimicrobial agents and chemotherapyMacrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals. Antimicrob Agents Chemother. 2014; 58(3):1738-43.Antimicrob Agents Chemother2014-01-06T00:00:002014Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals.24569451Kontoyiannis DPVirulenceAre respiratory complications more likely in patients with pulmonary aspergillosis treated with echinocandins in the setting of neutrophil influx? Virulence. 2014 Apr 01; 5(3):375-7.Virulence2014-02-25T00:00:002014Are respiratory complications more likely in patients with pulmonary aspergillosis treated with echinocandins in the setting of neutrophil influx?24590477Gomes MZ, Jiang Y, Mulanovich VE, Lewis RE, Kontoyiannis DPAntimicrobial agents and chemotherapyEffectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia. Antimicrob Agents Chemother. 2014 May; 58(5):2775-80.Antimicrob Agents Chemother2014-03-03T00:00:002014Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia.24758620Kontoyiannis DP, Mathur M, Chen YB, Shellito PC, Tse JYThe New England journal of medicineCase records of the Massachusetts General Hospital. Case 13-2014. A 41-year-old man with fever and abdominal pain after stem-cell transplantation. N Engl J Med. 2014 Apr 24; 370(17):1637-46.N Engl J Med2014-04-24T00:00:002014Case records of the Massachusetts General Hospital. Case 13-2014. A 41-year-old man with fever and abdominal pain after stem-cell transplantation.24446760Ariza-Heredia EJ, Kontoyiannis DPMycosesOur recommendations for avoiding exposure to fungi outside the hospital for patients with haematological cancers. Mycoses. 2014 Jun; 57(6):336-41.Mycoses2014-01-22T00:00:002014Our recommendations for avoiding exposure to fungi outside the hospital for patients with haematological cancers.24682112Katragkou A, Pana ZD, Perlin DS, Kontoyiannis DP, Walsh TJ, Roilides EMedical mycologyExserohilum infections: review of 48 cases before the 2012 United States outbreak. Med Mycol. 2014 May; 52(4):376-86.Med Mycol2014-03-28T00:00:002014Exserohilum infections: review of 48 cases before the 2012 United States outbreak.24719442Zhao Y, Armeanu E, DiVerniero R, Lewis TA, Dobson RC, Kontoyiannis DP, Roilides E, Walsh TJ, Perlin DSJournal of clinical microbiologyFungal DNA detected in blood samples of patients who received contaminated methylprednisolone injections reveals increased complexity of causative agents. J Clin Microbiol. 2014 Jun; 52(6):2212-5.J Clin Microbiol2014-04-09T00:00:002014Fungal DNA detected in blood samples of patients who received contaminated methylprednisolone injections reveals increased complexity of causative agents.24920954Jung DS, Kontoyiannis DPTuberculosis and respiratory diseasesCo-infection with Influenza: Do Not Forget Aspergillus in the Immunosuppressed Neutropenic Host. Tuberc Respir Dis (Seoul). 2014 May; 76(5):249.Tuberc Respir Dis (Seoul)2014-05-29T00:00:002014Co-infection with Influenza: Do Not Forget Aspergillus in the Immunosuppressed Neutropenic Host.24637687Farmakiotis D, Tarrand JJ, Kontoyiannis DPAntimicrobial agents and chemotherapyEfficacy and tolerability of micafungin monotherapy for candidemia and deep-seated candidiasis in adults with cancer. Antimicrob Agents Chemother. 2014 Jun; 58(6):3526-9.Antimicrob Agents Chemother2014-03-17T00:00:002014Efficacy and tolerability of micafungin monotherapy for candidemia and deep-seated candidiasis in adults with cancer.24799631Thompson GR, Albert N, Hodge G, Wilson MD, Sykes JE, Bays DJ, Firacative C, Meyer W, Kontoyiannis DPInfection and immunityPhenotypic differences of Cryptococcus molecular types and their implications for virulence in a Drosophila model of infection. Infect Immun. 2014 Jul; 82(7):3058-65.Infect Immun2014-05-05T00:00:002014Phenotypic differences of Cryptococcus molecular types and their implications for virulence in a Drosophila model of infection.25002471Kumaresan PR, Manuri PR, Albert ND, Maiti S, Singh H, Mi T, Roszik J, Rabinovich B, Olivares S, Krishnamurthy J, Zhang L, Najjar AM, Huls MH, Lee DA, Champlin RE, Kontoyiannis DP, Cooper LJProceedings of the National Academy of Sciences of the United States of AmericaBioengineering T cells to target carbohydrate to treat opportunistic fungal infection. Proc Natl Acad Sci U S A. 2014 Jul 22; 111(29):10660-5.Proc Natl Acad Sci U S A2014-07-07T00:00:002014Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.25006721McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJThe New England journal of medicineMold infections of the central nervous system. N Engl J Med. 2014 Jul 10; 371(2):150-60.N Engl J Med2014-07-10T00:00:002014Mold infections of the central nervous system.25028731Kontoyiannis DP, Lewis REAntimicrobial agents and chemotherapyReply to "Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?". Antimicrob Agents Chemother. 2014 Aug; 58(8):4990-1.Antimicrob Agents Chemother2014-08-01T00:00:002014Reply to "Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?".25143421Zhao Y, Kontoyiannis DP, Roilides E, Walsh TJ, Perlin DSJournal of clinical microbiologyReply to "not over yet: fungal infections following methyl prednisolone injections smoulder on". J Clin Microbiol. 2014 Sep; 52(9):3508.J Clin Microbiol2014-09-01T00:00:002014Reply to "not over yet: fungal infections following methyl prednisolone injections smoulder on".25143425Zhao Y, Kontoyiannis DP, Roilides E, Walsh TJ, Perlin DSJournal of clinical microbiologyReply to "detection of multiple fungal species in blood samples by real-time PCR: an interpretative challenge". J Clin Microbiol. 2014 Sep; 52(9):3517.J Clin Microbiol2014-09-01T00:00:002014Reply to "detection of multiple fungal species in blood samples by real-time PCR: an interpretative challenge".25268492Shirazi F, Farmakiotis D, Yan Y, Albert N, Do KA, Kim-Anh D, Kontoyiannis DPPloS oneDiet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis. PLoS One. 2014; 9(9):e108635.PLoS One2014-09-30T00:00:002014Diet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis.25182639Lewis RE, Albert ND, Kontoyiannis DPAntimicrobial agents and chemotherapyComparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis. Antimicrob Agents Chemother. 2014 Nov; 58(11):6767-72.Antimicrob Agents Chemother2014-09-02T00:00:002014Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.25199774Jung DS, Tverdek FP, Kontoyiannis DPAntimicrobial agents and chemotherapySwitching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity. Antimicrob Agents Chemother. 2014 Nov; 58(11):6993-5.Antimicrob Agents Chemother2014-09-08T00:00:002014Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity.24837401Farmakiotis D, Shirazi F, Zhao Y, Saad PJ, Albert ND, Roilides E, Walsh TJ, Perlin DS, Kontoyiannis DPThe Journal of infectious diseasesMethylprednisolone enhances the growth of Exserohilum rostratum in vitro, attenuates spontaneous apoptosis, and increases mortality rates in immunocompetent Drosophila flies. J Infect Dis. 2014 Nov 01; 210(9):1471-5.J Infect Dis2014-05-15T00:00:002014Methylprednisolone enhances the growth of Exserohilum rostratum in vitro, attenuates spontaneous apoptosis, and increases mortality rates in immunocompetent Drosophila flies.